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Abstract 
 
 Neurons exhibit highly polarized structures, including two morphologically and 
functionally distinct domains, axons and dendrites.  Dendrites and axons receive versus 
send information, and proper execution of each requires different sets of molecules. 
Differential distribution of membrane proteins in distinct neuronal compartments plays 
essential roles in neuronal functions. The major goal of my doctoral thesis was to study 
the molecular mechanisms that govern the differential distribution of membrane proteins 
in neurons, using the Drosophila larval mushroom body (MB) as a model system. 
 My work was initiated by an observation of differential distribution of distinct 
Dscam isoforms in neurons. Dscam stands for Down Syndrome Cell Adhesion Molecule, 
which is a Drosophila homolog of human DSCAM. According to genomic analysis, 
Drosophila Dscam gene can generate more than 38,000 isoforms through alternative 
splicing in its exons 4, 6, 9 and 17. All Dscam isoforms share similar domain structures, 
with 10 immunoglobulin domains and 6 fibronectin type III repeats in the ectodomain, a 
single transmembrane domain and a cytoplasmic endodomain. There are two alternative 
exons  in exon 17 (17.1 and 17.2), which encodes Dscam’s transmembrane domain. 
Interestingly, in ectopic expression, Dscam isoforms carrying exon 17.1 (Dscam[TM1]) 
can be preferentially localized to dendrites and cell bodies, while Dscam isoforms 
carrying exon 17.2 (Dscam[TM2]) are distributed throughout the entire neuron including 
axons and dendrites.   
 To unravel the mechanisms involved in the differential distribution of 
Dscam[TM1] versus Dscam[TM2], I conducted a mosaic genetic screening to identify the 
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possible factors affecting dendritic distribution of Dscam[TM1], established an in vivo 
TARGET system to better distinguish the differential distribution of Dscam, identified 
the axonal and dendritic targeting motifs of Dscam molecules and further showed that 
Dscam’s differential roles in dendrites versus axons are correlated with its localization.  
 Several mutants affecting dendritic distribution of Dscam[TM1] have been 
identified using a MARCM genetic screen. Three of these mutants (Dlis1, Dmn and p24) 
are components of the dynein/dynactin complex. Silencing of other dynein/dynactin 
subunits and blocking dynein function with a dominant-negative Glued mutant also 
resulted in mislocalization of Dscam[TM1] from dendrites to axons. However, 
microtubule polarity in the mutant axons was maintained. Taken together, this was the 
first demonstration that the dynein/dynactin complex is involved in the polarized 
distribution of membrane proteins in neurons. To further examine how dynein/dynactin is 
involved in the dendritic distribution of Dscam[TM1], I compromised dynenin/dynactin 
function with dominant-negative Glued and transiently induced Dscam[TM1] expression. 
The results suggested that dynein/dynactin may not be directly involved in the targeting 
of newly synthesized Dscam[TM1] to dendrites. Instead, it plays a role in maintaining 
dendritic restriction of Dscam[TM1].  Notably, dynein/dynactin dysfunction did not alter 
distribution of another dendritic transmembrane protein Rdl (Resistant to Dieldrin), 
supporting involvement of diverse mechanisms in distributing distinct molecules to the 
dendritic membrane. 
 To identify the targeting motifs of Dscam, I incorporated the TARGET (Temporal 
and regional gene expression targeting) system into mushroom body (MB) neurons, and 
this allowed the demonstration of the differential distribution of Dscam[TM1] and 
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Dscam[TM2] with more clarity than conventional overexpression techniques. Using the 
TARGET system, I identified an axonal targeting motif located in the cytoplasmic 
juxtamemebrane domain of Dscam[TM2]. This axonal targeting motif is dominant over 
the dendritic targeting motif located in Dscam’s ectodomain. Scanning alanine 
mutagenesis demonstrated that two amino acids in the axonal targeting motif were 
essential for Dscam’s axonal distribution. Interestingly, swapping the cytoplasmic 
juxtamembrane portions between TM1 and TM2 not only reversed TM1’s and TM2’s 
differential distribution patterns but also their functional properties in dendrites versus 
axons.  
 My thesis research also involved studying endodomain diversity of Dscam 
isoforms. Besides the diversity originally found in the ectodomain and transmembrane 
domain of Dscam, my colleagues and I further demonstrated the existence of four 
additional endodomain variants. These four variants are generated by skipping or 
retaining exon 19 or exon 23 through independent alternative splicing. Interestingly, 
different Dscam endodomain isoforms are expressed at different developmental stages 
and in different areas of the nervous system. Through isoform-specific RNA interference, 
we showed the differential involvement of distinct Dscam endodomains in specific 
neuronal morphogenetic processes. Analysis of the primary sequence of the Dscam 
endodomain indicated that endodomain variants may confer activation of different 
signaling pathways and functional roles in neuronal morphogenesis.  
 In Summary, my thesis work identified and characterized several previously 
unknown mechanisms related to the differential distribution of membrane proteins in 
neurons. I showed that there may be a dynein/dynactin-independent mechanism for 
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selective transport of dendritic membrane proteins to dendrites. Second, dynein/dynactin 
plays a maintenance role in dendritic restriction of Dscam[TM1]. Third, different 
membrane proteins may require distinct combinations of mechanisms to be properly 
targeted and maintained in certain neuronal compartments. Further analysis of the 
mutants indentified from my genetic screen will definitely help to resolve the missing 
pieces of the puzzle. These findings provide novel mechanistic insight into the 
differential distribution of membrane proteins in polarized neurons.     
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 Neuroscience is a field devoted to the scientific study of the nervous system. The 
complexity and diversity in the nervous system depends on the interconnections between 
neurons. Since the time of Cajal, it has been understood that each neuron is highly 
polarized and is comprised of a cell body called the soma, multiple dendrites and a single 
long axon. Dendrites bring information to the cell body, and axons take information away 
from the cell body. Dendrites and axons require distinct sets of cell surface molecules to 
perform distinct electrophysiological functions. Doubtlessly, proper sorting, targeting and 
maintenance of these cell surface molecules into different compartments are essential for 
all basic neuronal activities. The major goal of this thesis is to elucidate the molecular 
mechanisms underlying polarized distribution of cell surface proteins in neurons.  
Neuronal Polarity 
 The concept of neuronal polarity can be traced back to 140 years ago when Otto 
Dieters described the morphology of neurons. It took another thirty years to appreciate 
the significance of these morphological features with the proposition by Santiago Ramón 
y Cajal. “The law of dynamic polarization”, proposed by Cajal, stated that neurons are 
polarized, receive information on their cell bodies and dendrites, and conduct information 
to distant locations through axons (Cajal, 1989). Although many exceptions have been 
found to this rule, it remains a basic principle regarding the functioning of neuronal 
connections.  
 Apart from the differences in gross morphology, how do dendrites and axons 
differ?  One of the clear molecular differences was found to exist between the dendritic 
and axonal cytoskeletons. The polarity orientation of microtubules in the dendrites and 
axons of cultured rat hippocampal neurons are different (Baas et al., 1988; Black and 
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Baas, 1989). Microtubules in axons are uniformly oriented with the plus-end pointed 
away from the cell body toward the tips of axons; in contrast, microtubules in dendrites 
are arranged with mixed polarity. This organization of microtubules has also been 
suggested in Drosophila axons and dendrites (Stone et al., 2008; Zheng et al., 2008). 
Furthermore, some microtubule-associated proteins (MAPs) were found exclusively in 
dendrites (e.g. MAP2) or axons (e.g. Tau) (Kosik and Finch, 1987). These studies 
revealed that microtubules in dendrites and axons vary in both organization and 
composition.   
The polarized distribution of molecules is essential to neuronal function      
 Dendrites and axons differ not only in morphology and structure but also in 
function. Proper cellular morphology and function depends on the polarized distribution 
of organelles and proteins in distinct subcellular compartments. For example, in 
mammalian and fly neurons, Golgi outposts localize to dendrites and influence dendritic 
branching. Mislocalization of Golgi outposts in neurons parallels change in branch 
distribution (Ye et al., 2007; Zheng et al., 2008).  
 Distinct protein composition exists not only in the cytoplasm, but also on the 
plasma membrane. The polarized distribution of many cell surface proteins including ion 
channels, receptors and cell adhesion molecules has been shown to be essential for all 
basic neuronal functions and activities (Craig et al., 1994; Endoh, 2004). For instance, 
dendritic voltage-gated channels have been proposed to play a critical role in regulating 
the propagation of synaptic signals and action potentials in dendrites (Stuart et al., 1997). 
Dendritic voltage-gated potassium channels (e.g. Kv2.1 and Kv2.2) which undergo 
slower inactivation than axonal voltage-gated potassium channels (e.g. Kv1.3 and Kv1.4) 
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prevent back-propagation of action potentials into the dendrites (Wei et al., 1990; 
Hoffman et al., 1997). In addition, certain metabotropic glutamate receptors, including 
mGluR1a and mGluR2, also show polarized distribution (Stowell and Craig, 1999), and 
potentially underlie differential glutamate effects in different compartments of neurons 
(Nakanishi, 1992; Endoh, 2004).   
The mechanisms involved in the polarized distribution of cell surface proteins 
 Neuroscientists have long been interested in how different neuronal membrane 
proteins are segregated and correctly maintained. To dissect out this fundamental 
problem, studies in cultured rat hippocampal neurons and epithelial cells such as Madin-
Darby canine kidney (MDCK) cells have provided significant insight into the highly 
conserved mechanisms that establish and maintain polarity (reviewed in Horton and 
Ehlers, 2003). For example, neurons recognize the same targeting motifs for 
somatodendritic targeting that epithelial cells use for basolateral targeting (West et al., 
1997; Stowell and Craig, 1999). Indeed, it is believed that the basolateral and apical 
compartments of epithelial cells may correspond to the somatodendritic and axonal 
compartments of neurons, respectively (Dotti and Simons, 1990; Matter and Mellman, 
1994).  
 This polarized distribution is thought to begin with the sorting of membrane 
proteins into distinct populations of carrier vesicles (Keller et al., 2001). These vesicles 
are transported out toward the dendrites or axons by ‘smart’ motor proteins, which can 
recognize sorting signals on membrane proteins and distinguish different microtubules 
that lead to different destinations. Once at the plasma membrane, distinct mechanisms 
work to achieve selective fusion and retention of these proteins (Goldstein and Yang, 
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2000; Tang, 2001; Dotti and Poo, 2003). In addition, a diffusion barrier is formed 
between certain subcellular compartments to prevent free lateral diffusion of membrane 
proteins in the plane of plasma membrane (Nakada et al., 2003). Although numerous 
results and discoveries provide us a rough picture of the molecular events underlying 
polarized distribution processes in neurons, understanding of the mechanistic details 
remains incomplete. For instance, what molecules are involved in each process? How are 
different membrane proteins sorted into distinct vesicles? How do molecular motors 
recognize the intrinsic cues from vesicular cargo and microtubules? One issue 
complicating further elucidation of these questions is that there is no one universal or 
predominant mechanism that functions across different membrane proteins and all cell 
types. Multiple mechanisms can contribute to the polarized distribution of a single 
membrane protein, and different membrane proteins can adopt different mechanisms to 
achieve and maintain their polarized distribution patterns. To investigate these important 
questions, identification of additional intrinsic sorting signals and the protein machinery 
that recognizes them will assist in a molecular dissection of neuronal polarity and protein 
targeting.  
 
Polarized distribution of different Drosophila Down Syndrome cell adhesion 
molecule (Dscam) isoforms    
 Drosophila Down Syndrome cell adhesion molecule (Dscam) is a homolog of 
human DSCAM. Down syndrome in humans is a congenital disorder with intellectual 
impairment and physical abnormalities, and is caused by the existence of a triple 
chromosome 21 and related DSCAM over-expression. Notably, Dscam has been shown 
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to be widely involved in neuronal morphogenesis in the Drosophila brain. Either loss or 
over-expression of the Dscam protein perturbs segregation of axonal branches in the 
mushroom bodies (MBs), alters target specificity in olfactory receptor neurons (ORNs), 
impedes axonal growth and extension in mechanosensory neurons and causes self-
avoidance defects in dendritic arborization (da) neurons (Schmucker et al., 2000; Wang et 
al.,2002; Hummel et al., 2003; Chen et al., 2006; Soba et al., 2007; Mathews et al., 2007).  
 Drosophila Dscam is a cell surface molecule which belongs to the 
immunoglobulin-fibronectin superfamily. According to genomic and cDNA analysis, the 
Dscam gene encodes potentially 152,064 isoforms through alternative splicing (Figure 1-
1A) (Schmucker et al., 2000; Wang et al., 2004). Dscam’s extracellular domain contains 
three variable regions that are encoded by one of 12 exon 4 alternatives, one of 48 exon 6 
alternatives and one of 33 exon 9 alternatives, respectively. In addition, its 
transmembrane domain is encoded by one of two exon 17 alternatives (exon 17.1 and 
exon 17.2). In Dscam’s endodomain, exons 19 and 23 can be independently deleted to 
generate another four different combinations.  
 Remarkably, when different GFP-tagged Dscam trangenes are individually 
expressed in the Drosophila mushroom body (MB) neurons, we observe two distinct 
protein distribution patterns. Those Dscam isoforms with their transmembrane domains 
derived from exon 17.1 (termed Dscam[TM1]) are preferentially localized in the cell 
bodies and dendrites (Figure 1-1C). In contrast, Dscam isoforms carrying exon 17.2 
(termed Dscam[TM2]) are always distributed throughout cell bodies, dendrites, and 
axons (Figure 1-1D) (Wang et al., 2004; Zhan et al, 2004). Expression at low level with 
the Dscam promoter, Dscam[TM1]-GFP is preferentially localized to dendrites, while 
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Dscam[TM2]-GFP is largely restricted to axons. With regards to the endodomain, Dscam 
isoforms with exon 19 (termed Dscam+19) tend to accumulate more in the cell body 
regions than Dscam isoforms without exon 19 (termed Dscam-19). These differential 
distribution patterns can also be observed in other model neurons in Drosophila, such as 
the projection neurons (PNs). These phenomena raised my interest in studying the 
underlying mechanisms of Dscam’s differential distribution in neurons and examining 
whether the polarized distribution of Dscam is associated with its diverse functions in 
vivo.  
  
The Drosophila Mushroom Bodies (MBs) as a model system to study the polarized 
distribution of Dscam 
 Previously, we found that a lethal mutation in Dscam specifically perturbs 
segregation of axonal branches in the Drosophila mushroom bodies (MBs) (Wang et al., 
2002). To examine possible involvement of distinct Dscam isoforms in different neuronal 
morphogenetic processes and how its polarized distribution was related to these 
processes, I used the MBs as a model system to explore these questions.    
 The MBs, prominent structures in the Drosophila brain, are the center of olfactory 
associative learning and memory and are functionally equivalent to the hippocampus in 
mammals (Heisenberg, 2003). Drosophila MBs are paired neuropil structures, one in 
each hemisphere (Figure 1-2A). Each MB consists of approximately 2,500 small neurons 
called Kenyon cells (Ito et al, 1997). The cell bodies are located in the dorsal and 
posterior cortex of the brain. Their dendrites form the ball-shaped protrusion called the 
calyx located below the cell body region. The dendrites mainly receive olfactory inputs 
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from projection neurons (PNs) in the antennal lobe (Stocker et al., 1990), which is the 
Drosophila counterpart of the mammalian olfactory bulb. MB neurons extend their axons 
as a bundle through a stalk-like structure named the peduncle toward the anterior margin 
of the brain, where the axons project into five lobes: γ, α’, β’, α and β lobes (Figure 1-2B) 
(Crittenden et al., 1998; Lee et al., 1999).  
 The development and projection patterns of individual MB neurons have been 
well characterized (Figure 1-2C) (Lee et al., 1999). Systematic studies with mosaic 
expression systems showed that three distinct types of MB neurons are born in a birth 
order-dependent manner. γ neurons are born first, from late embryonic stage to the mid-
3rd instar larval stage, followed by α’/β’ neurons which are born between the mid-3rd 
instar larval stage and end of wandering larval stage. Afterward, the MB neuroblasts 
(Nbs) exclusively produce α/β neurons. γ neurons have different axonal projection 
patterns in larval and adult stages. At larval stages, axons of γ neurons bifurcate to form 
dorsal and medial lobes. During metamorphosis, γ neurons undergo dramatic remodeling. 
Shortly after puparium formation, larval-specific axons are pruned, followed by 
reextension of adult-specific axons which project medially into the γ lobes with multiple 
axonal arbors (Armstrong et al., 1998; Lee et al., 1999). α’/β’ and α/β neurons have 
bifurcated axonal projection patterns--they extend their axons perpendicularly into α’/β’ 
and α/β lobes, respectively. Therefore, distinct subtypes of MB neurons in different 
developmental stages can be easily identified based on their projection patterns.   
 Thus, using the Drosophila MB as a model system, we can study various aspects 
of neuronal function and development, such as neuronal remodeling, axon bifurcation,  
dendritic arborization, axonal growth and targeting, and protein distribution. In addition, 
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both candidate gene analysis and forward genetic screens have been conducted in the 
Drosophila MB and successfully identified genes involved in various poorly understood 
neuronal functions (Lee et al., 2000a; Lee et al., 2000b; Wang et al., 2002; Zheng et al., 
2003; Zhu et al., 2005; Wang et al., 2006; Zhu et al., 2006). Therefore, as part of my 
thesis research, I conducted a forward genetic screen in the Drosophila MB to identify 
molecules that are involved in the polarized distribution of Drosophila Dscam. I also 
used the Drosophila MB as a model system to study the functions of Dscam during 
neuronal development. 
 
Approaches: Mosaic analysis with a repressible cell marker (MARCM), temporal 
and regional gene expression targeting (TARGET) and microRNA-based RNAi  
 Based on the previous results, a forward genetic screen using MARCM was 
performed in order to identify novel genes required for polarized distribution of Dscam. 
MARCM, a positive-labeling genetic mosaic technique, has allowed us to generate 
homozygous mutant cells from heterozygous precursors via mitotic recombination (Lee 
et al., 1999; Lee and Luo, 1999). Dscam[TM1]::GFP was been incorporated into my 
MARCM screen as a reporter concentrated in MB calyx. This screen should allow me to 
uncover genes that are involved in the dendritic distribution of Dscam[TM1]. 
Dscam[TM2] could not be a reporter for a similar screen because ectopically 
overexpressed Dscam[TM2] showed no obvious polarized distribution pattern. Of 1,850 
mutant chromosome arms of 2R screened, I found 35 potentially interesting mutations 
that caused mislocalization of Dscam[TM1] from dendrites to axons. Judging from the 
phenotypes of mislocalization, I selected nine mutants for further study. 
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Complementation tests revealed three mutations in Lis1, p24, and Dynamitin (Dmn), 
which are all components of dynein/dynactin complex. Detailed phenotypic analysis 
showed that the dynein/dynactin complex is involved in the dendritic restriction of 
Dscam[TM1] expression, likely through a scavenger mechanism. (Please see Chapter II 
for more details.)   
 By utilizing the TARGET system in which GAL4-dependent expression of UAS-
transgenes is acutely controlled by a temperature-sensitive GAL4 repressor, GAL80ts 
(McGuire et al., 2003), transiently induced and newly synthesized Dscam molecules can 
be exclusively targeted to different neuronal compartments, using Dscam[TM1]::GFP in 
dendrites and Dscam[TM2]::GFP in axons. This transient induction system can detect 
distribution of proteins expressed at extremely low levels, which should better mimic the 
distribution of endogenous proteins. Through the use of the TARGET system, dendritic 
and axonal targeting motifs of Dscam were identified. The ectodomain of Dscam carries 
a dendritic targeting motif, and the cytoplasmic juxtamembrane portion of TM2 contains 
an axonal targeting motif. The axonal targeting motif is dominant over the dendritic 
targeting motif in Dscam. (Please see Chapter III for more details.) 
 To relate the polarized distribution of Dscam to its endogenous functions, 
microRNA-based RNAi technology was utilized to selectively knock down different 
subsets of Dscam proteins containing either exon 17.1 or exon 17.2. Target recognition of 
miRNA involves only 22 contiguous nucleotides, making it more feasible to silence 
expression of specific subsets of Dscam transcripts, which differ only in small alternative 
exons. We found that endogenous Dscam[TM1] and Dscam[TM2] primarily mediate 
dendritic elaboration and axonal arborization, respectively. Swapping the cytoplasmic 
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juxtamembrane portions between TM1 and TM2 reversed not only their polarized 
distribution patterns but also their distinct functions. Together, we concluded that 
functional differences between Dscam[TM1] and Dscam[TM2] likely rely on polarized 
protein targeting. (Please see Chapter IV for more details.) 
     Following this line of research, differential protein distribution patterns were 
also observed for Dscam isoforms with various endodomains. According to cDNA 
analysis, four Dscam endodomains can be generated from independent alternative 
splicing of exon 19 and exon 23. We found that transgenic Dscam without exon 19 is 
more efficiently targeted to neurites and more potently suppresses axon bifurcation in 
Dscam mutant neurons than exon 19-containing Dscam. To determine whether distinct 
Dscam endodomains are utilized to govern different Dscam-dependent neuronal 
morphogenetic processes, microRNAs against distinct endodomains and isoforms-
specific antibodies were generated. Intriguingly, the wiring of adult fly neural circuitry 
primarily involves Dscam isoforms lacking both exon 19 and exon 23.  However, Dscam 
with exon 19 plays a more dominant role than Dscam without exon 19 in supporting the 
wiring of embryonic neural circuitry. (Please see Chapter V for more details.)   
 In Summary, the work addressed in this thesis highlights the molecular 
mechanisms underlying the differential distribution of various Dscam isoforms and their 
functions in neuronal morphogenesis, with regard to their distribution. These results lay 
the foundation for future genetic and molecular studies to elucidate how neurons establish 
polarized distribution of membrane proteins for diverse neuronal activities.     
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Figure 1-1. Dscam isoforms and transgenic protein distribution.  
(A) Dscam potentially encodes 152,064 isoforms via alternative splicing in its exons 4, 6, 
9, 17, 19 and 23 (adapted from Schmucker et al., 2000; Wang et al., 2004). (B) GAL4-
201Y was used to drive expression of UAS-mCD8-GFP in MB neurons. (C) Ectopically 
expressed Dscam[TM1]::GFP was preferentially enriched in dendrites of MBs, called the 
MB calyx. (D) Ectopically expressed Dscam[TM2]::GFP was distributed throughout the 
entire MB neuron. (adapted from Wang et al., 2004).    
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Figure 1-2. The organization and development of Drosophila mushroom bodies 
(MBs).  
(A) Drosophila MBs in an adult brain are highlighted in green (adapted from Rein K, 
2000). (B) Close-up view of the MBs in the right hemisphere under the microscope. 
Individual axonal lobes are outlined with solid lines:  γ in red, α’/β’ in green and α/β in 
purple. (C) Schematic view of MB development. Three types of MB neurons are born in 
a specific temporal order (adapted from Lee et al., 1999). NHL, newly hatched larvae; 
ALH, after larval hatching; D, day. Scale bar unit: µm. 
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Chapter 2 
 
Dynein-dynactin complex is essential for dendritic restriction of TM1-
containing Drosophila Dscam 
 
 
 
 
 
 
The following work is reprinted from the PLoS ONE article of the same name published 
as: 
Jacob Shun-Jen Yang, Jia-Min Bai, and Tzumin Lee.  
PLoS ONE, Oct 2008: Vol. 3, Issue 10, e3504 
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ABSTRACT 
 Many membrane proteins, including Drosophila Dscam, are enriched in dendrites 
or axons within neurons.  However, little is known about how the differential distribution 
is established and maintained.  Here we investigated the mechanisms underlying the 
dendritic targeting of Dscam[TM1].  Through forward genetic mosaic screens and by 
silencing specific genes via targeted RNAi, we found that several genes, encoding 
various components of the dynein-dynactin complex, are required for restricting 
Dscam[TM1] to the mushroom body dendrites.  In contrast, compromising 
dynein/dynactin function did not affect dendritic targeting of two other dendritic markers, 
Nod and Rdl.  Tracing newly synthesized Dscam[TM1] further revealed that dynein-
dynactin is dispensable for the initial dendritic targeting of Dscam[TM1] and apparently 
plays a role in excluding dendritic Dscam from axons by retrograde transport. 
 
INTRODUCTION 
 Neurons exhibit highly polarized structures, including two morphologically and 
functionally distinct domains, axons and dendrites.  Dendrites and axons respectively 
receive or send information, proper execution of which requires different sets of 
molecules.  For example, in the mammalian brain and in cultured neurons, voltage-gated 
potassium channels of the Kv1 (Shaker) family reside in the axons.  In contrast, voltage-
gated potassium channel Kv2.1 and Kv2.2 are selectively enriched in the somatodendritic 
region (Lim et al., 2000; Monaghan et al., 2001; Gu et al., 2003).  The dendritic 
potassium channels undergo slower inactivation to prevent back-propagation of action 
potentials into the dendrites (Wei et al., 1990; Hoffman et al., 1997).  Certain 
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metabotropic glutamate receptors, including mGluR1a and mGluR2, also show polarized 
distribution (Stowell and Craig, 1999), and potentially underlie differential glutamate 
effects in different compartments of neurons (Nakanishi, 1992; Endoh, 2004). 
 
 One dominant model to explain the differential distribution of neuronal membrane 
proteins involves directed transport of vesicular cargos along the microtubules that 
extend into the dendrites and axons (Goldstein and Yang, 2000).  Microtubules have 
polarity; directed transport requires motors to move cargos toward the plus- or minus-end 
of the microtubules.  In axons microtubules are uniformly oriented with minus-ends 
pointing to the cell body, while microtubules exist with mixed polarity within the 
somatodendritic region (Bass et al., 1998).  This difference in microtubule organization 
supports the hypothesis that minus-end-directed motors are constantly moving molecules 
out of axons and may selectively transport their cargos into the dendrites (Burack et al., 
2000).  Identified minus-end-directed motors include dynein and C-terminal kinesins.  
Cytoplasmic dynein, which forms a large complex with its activator dynactin, is 
responsible for the retrograde transport in axons (reviewed in Goldstein and 
Gunawardena, 2000; Schroer, 2004).  Dynein/dynactin complex contains more than 
twenty subunits.  Although the functions of each subunit remain to be determined, it is 
believed that all the subunits act together to regulate the processivity and cargo-binding 
selectivity of dynein (King and Schroer, 2000; Schroer, 2004).  Various C-terminal 
kinesins (i.e. Ncd in Drosophila and KIFC2 in mouse), which carry their motor domain at 
the C-terminus, also move specifically toward the minus end.  But their real function in 
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vesicular transport is unclear (McDonald et al., 1990; Saito et al., 1997).  The role of 
minus-end-directed motors in dendritic protein targeting remains undocumented.  
 
Besides selective transport, additional mechanisms may contribute to the polarized 
distribution by differential depletion or stabilization.  For example, the steady-state 
axonal distribution of Nav1.2 and VAMP2 is primarily achieved through their selective 
removal by endocytosis from the dendritic plasma membrane (Garrido et al., 2001; 
Sampo et al., 2003).  Preferential fusion of vesicular cargos with different plasma 
membrane domains may mediate some polarized distribution as well.  One precedent for 
fusion selectivity involves targeting of distinct SNAREs to the apical or basolateral 
domains of epithelial MDCK cells (Low et al., 1996).  Other possible mechanisms 
include existence of diffusion barriers and/or protein stabilization by scaffold proteins.  
However, most of these studies shed light on the polarized distribution of axonal proteins; 
and little is known about dendritic protein targeting (Stowell and Craig, 1999; Horton and 
Ehlers, 2003; Rivera et al., 2003). 
 
 Drosophila Down Syndrome cell adhesion molecule (Dscam) is a transmembrane 
protein, which belongs to the immunoglobulin (Ig) superfamily.  Dscam is essential for 
diverse neuronal morphogenetic processes, including axon guidance, branch segregation, 
and dendritogenesis (Schmucker et al., 2000; Wang et al., 2002; Matthews et al., 2007; 
Soba et al., 2007).  Notably, Drosophila Dscam can encode thousands of isoforms 
through alternative splicing involving many choices of exon 4, 6, 9 and 17.  Distinct 
Dscam isoforms may be targeted to dendrites or axons, depending on which of the two 
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transmembrane-domain-encoding exon 17 alternatives, 17.1 or 17.2, is utilized (Wang et 
al., 2004).  Dscam isoforms carrying exon 17.1 (Dscam[TM1]) are largely restricted to 
dendrites, while Dscam isoforms with exon 17.2 (Dscam[TM2]) are enriched in axons.  
Further, depleting Dscam[TM1] or Dscam[TM2] blocks morphogenesis of dendrites 
versus axons (Shi et al., 2007).  Understanding how isoforms of Dscam are differentially 
distributed in neurons promises to shed new light on neuron polarity and its underlying 
mechanisms. 
 
 Here we performed genetic mosaic screens to identify genes required cell-
autonomously for the dendritic targeting of Dscam[TM1].  We obtained mutants that 
exhibit different mislocalization phenotypes.  We identified three mutations in the known 
components of dynein-dynactin complex (Lis1, p24 and Dynamitin) that all affect Dscam 
dendritic targeting.  Misdistribution of dendritic Dscam to axons was also observed when 
we suppressed the expression of other dynein/dynactin components with RNA 
interference.  However, microtubule polarity in the mutant axons was maintained.  
Transient induction of Dscam[TM1] further revealed that disrupting dynein/dynactin 
function did not affect the targeting of newly synthesized Dscam[TM1] to the dendrites.  
Instead, dendritic Dscam later diffused into the axons.  These observations indicate that 
dynein/dynactin plays a role in maintaining dendritic restriction of Dscam[TM1], and 
further suggest a dynein/dynactin-independent mechanism for the initial targeting of 
Dscam[TM1] to dendrites.  Notably, dynein/dynactin dysfunction did not alter 
distribution of another dendritic transmembrane protein Rdl (Resistant to Dieldrin), 
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supporting involvement of diverse mechanisms in locating distinct molecules to the 
dendritic membrane. 
 
MATERIALS AND METHODS 
Generation of UAS-mCD8::RFP 
The monomeric red fluorescence protein (mRFP) open reading frame (Campbell et al., 
2002) was amplified by PCR and was cloned into the mCD8-comtaining pBS (Lee and 
Luo, 1999) with BamHI and XbaI as the cloning sites, generating a new ORF with mRFP 
fused in frame to the 3’ of mCD8. Then, mCD8::RFP was subcloned into pUAST (Brand 
and Perrimon, 1993) with XhoI and XbaI as the cloning sites. pUAST-mCD8::RFP 
transgene was introduced into the fly genome via P element-mediated germline 
transformation by Genetic Services Inc., MA.  
 
Fly Stocks and Crosses 
For creation of MARCM clones, we crossed UAS-mCD8::RFP; hs-FLP, FRTG13, tubP-
GAL80/CyO,Y  to either wildtype or mutagenized UAS-Dscam[TM1]::GFP, FRTG13, 
GAL4-201Y/CyO,Y.   UAS-Nod-β-gal (Lee et al., 2000b) or UAS-Rdl-HA (Sanchez-
Soriano et al., 2005) was incorporated on third or X chromosomes, respectively, for 
examining their distribution in MARCM clones. 
    For acute induction by TARGET system, we crossed UAS-Dscam[TM1]::GFP or 
UAS-mCD8::GFP to tubP-GAL80ts; tubP-GAL80ts; GAL4-OK107 . UAS-dominant-
negative Glued, P[UAS-GlΔ84], (Allen et al., 1999) was used to block dynein/dynactin 
function. To increase copy numbers of P[UAS- GlΔ], we generated another two insertion 
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lines on third chromosome (UAS-GlΔ008m and UAS-GlΔ020m ) by hopping out P[UAS-
GlΔ84]  from second chromosome.  
 Other flies stocks collected for this study include Dmnk16109/CyO (BL-11159), 
l(2)06496  /CyO (BL-12316), Lis-1k13209/CyO (BL-11072), tubP-GAL80ts;Tm2/Tm6B 
(BL-7019), noc/CyO; tubP-GAL80ts (BL-7018), and RNAi lines from VDRC stock center 
(Dietzl et al., 2007), including CG8446RNAi (23139), Lis1RNAi (6216), DmnRNAi 
(23728), p25RNAi (8058), Dhc64CRNAi (28054), Dhc62BRNAi (48153) and 
Dlc90FRNAi (31750).  
 
MARCM-based Genetic Screens and Analysis of MARCM Clones 
Chemical mutagenesis was conducted in the UAS-Dscam[TM1]::GFP, FRTG13, GAL4-
201Y male flies using standard procedure (Lewis and Bacher, 1968) with an EMS 
concentration of 40 mM. Individual male progeny derived from the mutagenized flies 
were then crossed with mCD8::RFP; hs-FLP, FRTG13, tubP-GAL80 for MARCM 
analysis of MB clones. To induce mitotic recombination, newly hatched larvae were heat 
shocked in a 38℃ water bath for one hour and then returned to 25℃. The central nervous 
systems from wandering third instar larvae were dissected out, fixed and immunostained 
as previously described (Lee and Luo, 1999). Protein expression was detected by the 
rabbit anti-GFP Ab (1:300, Molecular Probes) and MB lobes were labeled by the 1D4 
mAb (1:80). Immunofluorescent signals were collected by confocal microscopy and then 
processed using Adobe Photoshop to normalize and exclude the background neurons. 
 
Deficiency Mapping and Complementation Testing 
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Following screening, the homozygous lethal mutants were mapped initially by crossing to 
the second chromosome deficiency kit, provided by the Bloomington Drosophila Stock 
Center.  We performed further fine scale mapping with smaller deficiencies to define the 
minimal regions containing the lethal mutations. Lines mapped to the similar regions 
were placed in complementation groups by the complementation testing. Eventually, we 
tested candidate genes in these regions with available lethal mutant lines from 
Bloomington.  
 
Acute Induction of UAS-transgenes by TARGET system 
Larvae carrying two copies of tubP-GAL80ts (McGuire et al., 2003) were cultured at the 
permissive temperature of 18°C since embryogenesis in order to repress GAL4-mediated 
transcription.  Wandering larvae were shifted to 38°C for 30 min, followed by incubation 
at the non-permissive temperature of 29°C for various periods.  
 
RESULTS  
Drosophila Dscam[TM1] as a dendritic marker for genetic mosaic analysis of 
dendritic protein targeting 
 We have previously shown that transgenic Dscam carrying the exon 17.1-
encoding transmembrane domain (referred to as Dscam[TM1] as opposed to 
Dscam[TM2] that carries exon 17.2) is selectively targeted to dendrites.  When 
ectopically expressed in the neurons of the Drosophila olfactory learning and memory 
center, the mushroom bodies (MBs), Dscam[TM1]::GFP exists abundantly in the calyx 
where MB dendrites are located, but could not be detected in the axons which extend 
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through the peduncle before entering the MB lobes (Figures 2-1B, C and C’).  MARCM, 
a positive-labeling genetic mosaic technique, has allowed us to effectively generate 
clones of MB neurons that are homozygous for a specific chromosome arm in an 
otherwise heterozygous organism and simultaneously express a reporter gene in an 
unlabeled background (Lee and Luo, 1999; Lee et al., 1999).  Using mCD8::GFP as a 
reporter to visualize the morphology of the MBs, we have been screening for genes 
required for various aspects of MB development through loss-of-function genetic mosaic 
analysis (Lee et al., 2000a; Wang et al., 2002; Wang et al., 2006; Zheng et al., 2003; Zhu 
et al., 2005; Zhu et al., 2006).  We reasoned that incorporating Dscam[TM1]::GFP into 
our MARCM screens should allow us to uncover genes, regardless of their possible 
involvement in other essential cellular events, that are essential for proper dendritic 
targeting of Dscam[TM1]::GFP.  Our goal was to fully elucidate the cellular/molecular 
mechanisms of dendritic protein targeting. 
 
 To adapt the system for genetic mosaic screens on dendritic protein targeting, we 
incorporated UAS-mCD8::RFP and UAS-Dscam[TM1]::GFP into MARCM (Figure 2-
1A).  In combination with GAL4-201Y, a MB GAL4 enhancer trap line, we 
simultaneously expressed Dscam[TM1]::GFP and mCD8::RFP in the MB clones and 
directly examined Dscam[TM1]::GFP distribution inside the MBs of live mosaic larval 
brains (Figure 2-1C).  While mCD8::RFP outlined the entire clone (Figure 2-1C’, red), 
Dscam[TM1]::GFP was well restricted to the MB calyx in wild-type clones (Figure 2-
1C).  Using this as readout, we screened 1,850 chemically mutagenized 2R chromosome 
arms for mutations that affect the dendritic restriction of Dscam[TM1]::GFP.  We 
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recovered 35 mutant lines that exhibited abnormal Dscam[TM1]::GFP protein 
distribution patterns.  We clustered them into four groups according to their phenotypes.  
Group I consisted of 9 independent lines that showed significant Dscam[TM1]::GFP 
accumulation in both MB peduncles and lobes (e.g. Figures 2-1D and D’).  Group II 
carried mutations that have mistargeted Dscam[TM1]::GFP gradually disappeared along 
the MB axon bundles (e.g. Figures 2-1E and E’).  In Group III, Dscam[TM1]::GFP 
becomes restricted to MB cell bodies (e.g. Figures 2-1F and F’), while mutations in group 
IV disrupted gross MB morphology (e.g. Figures 2-1G and G’).  All the recovered lines 
were lethal as homozygotes, thus it would be impossible to systematically uncover the 
genes required for dendritic protein targeting as well as organism viability without 
genetic mosaics.  In the following work, we selectively focused on group I mutants that 
displayed mistargeting of dendritic Dscam more uniformly throughout the MBs. 
 
Analysis of mutants that exhibited aberrant accumulation of Dscam[TM1]::GFP in 
axons 
 Detailed analysis of group 1 mutants further revealed subclasses of 
misdistribution phenotypes.  Five of the nine mutants exhibited granular accumulation of 
Dscam[TM1]::GFP in the MB lobes (e.g. Figures 2-2A-D), three had Dscam[TM1]::GFP 
selectively accumulated in the peduncle (e.g. Figure 2-2E), and the last one showed broad 
non-granular distribution of Dscam[TM1]::GFP (e.g. Figure 2-2F). In addition, many of 
the mutant clones were smaller than controls (e.g. Figure 2-1H). Two of the lines with 
granular accumulation had reduced calycal volume, suggesting possible defects in 
dendritic morphogenesis.  These phenomena indicated that genes involved in dendritic 
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protein targeting potentially underlie multiple fundamental cellular functions.  Further, 
the identification of several clusters of misdistribution phenotypes suggested the 
involvement of multiple mechanisms in restricting Dscam[TM1] to dendrites. 
 
 Complementation among the mutations yielded six complementation groups. 
Mapping against deficiency lines and other known mutations further revealed that 
mutations in Lis1, p24, and Dynamitin (Dmn) constituted three of the four 
complementation groups which showed mistargeted Dscam[TM1]::GFP in granules 
(Figures 2-2A-C, arrows).  Both lines that exhibited defective dendritic morphogenesis 
carried mutations in Lis1 (Figure 2-2A’, arrowhead).  Lis1, a mutation of which underlies 
human lissencephaly, is a regulatory protein of the microtubule motor dynein, and is 
highly conserved from human to Drosophila.  Drosophila Lis1 has been shown to play an 
essential role in MB neurogenesis and dendritic elaboration (Reiner et al., 1993; Swan et 
al., 1999; Liu et al., 2000).  However, it has never been shown to be involved in 
differential distribution of cell surface proteins.  p24 (CG9893) is a novel molecule that 
may be integral to the dynactin complex, as implicated from its sequence and structural 
similarity with vertebrate DCTN3 (Goldstein and Gunawardena, 2000).  p50/Dmn is also 
a dynactin subunit.  The dynactin complex regulates the cargo selection and processivity 
of dynein. Mutations in the dynactin complex can affect the assembly of dynein/dynactin 
complex and its binding affinity for microtubules (Puls et al., 2003; Schroer, 2004; Clark 
and Rose, 2005).  The recovery of multiple dynein/dynactin components and regulators 
indicates that proper dynein/dynactin function is essential for the restriction of 
Dscam[TM1]::GFP to dendrites. 
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Requirement of dynein-dynactin complex for the restriction of Dscam[TM1]::GFP 
to dendrites 
 In order to substantiate the involvement of dynein-dynactin complex, we first 
confirmed that Lis1, Dmn, and p24 are required for the dendritic restriction of 
Dscam[TM1]::GFP using reagents independent of our genetic screen.  Genes could be 
effectively silenced in the MBs by RNA interference (RNAi) (Didelot et al., 2006; Shi et 
al., 2007); and transgenic flies carrying UAS-RNAi against various Drosophila genes, 
including Lis1, Dmn, and many other components of dynein-dynactin complex, are 
available in the Vienna Drosophila RNAi Center (VDRC) (Dietzl et al., 2007).  
Encouragingly, silencing Lis1 or Dmn, as opposed to various control genes (such as 
CG8446 and CG18247), by targeted RNAi effectively mislocalized transgenic 
Dscam[TM1]::GFP to MB axon lobes (Figures 2-3A-C). These results not only 
confirmed the roles of Lis1 and Dmn, but also illustrated the utility of RNAi in quickly 
uncovering more genes in a common pathway.  We confirmed the indispensability of p24 
in Dscam localization by examining Dscam[TM1]::GFP distribution in MB clones 
homozygous for a pre-existing loss-of-function allele of p24 (data not shown). Analogous 
mislocalization phenotypes were obtained when Lis1, Dmn, or p24 were depleted by 
various means, substantiating their involvement, possibly through the dynein-dynactin 
complex, in excluding dendritic Dscam from axons. 
 
 Further, we knocked down additional components of the dynein/dynactin complex 
(Figure 2-3J), including dynein heavy chains (Dhc64C and Dhc62B), dynein light chain 
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(Dlc90F), and another dynactin subunit (p25), by targeted RNAi.  Aberrant accumulation 
of dendritic Dscam in the MB axons was detected in all the cases (Figures 2-3D-G), 
though the detailed mislocalization patterns varied depending on which gene was 
silenced.  For example, targeting RNAi against Lis1, Dmn or Dhc64C caused excessive 
accumulation of dendritic Dscam near the ends of the axonal lobes (Figures 2-3B-D, 
arrowheads), while Dscam[TM1] uniformly distributed throughout the axonal lobes 
following depletion of Dhc62B, Dlc90F or p25 (Figures 2-3E- G, arrows).  These 
different phenotypes could be derived from different residual dynein/dynactin function 
due to partial knockdown or differential redundancy.  Alternatively, they might result 
from crippling distinct aspects of Dscam protein targeting, since it remains unclear as to 
the individual proteins’ full spectra of function (see Discussion).  Notably, 
simultaneously depleting either two of Dhc62B, Dlc90F or p25 shifted the 
misdistribution from the peduncle to the lobes (e.g. Figures 2-3H and I), better 
recapitulating the terminal accumulation phenotype in other dynein/dynactin mutants.  
These results indicate that all these molecules act through dynein/dynactin complexes to 
restrict Dscam[TM1] to dendrites.  
 
 In addition, the role of Glued was determined through inhibition of its function by 
a dominant-negative Glued (GlΔ ) (Allen et al., 1999).  Glued is the largest subunit of 
dynactin complex and plays a particular important role in dynein binding and 
enhancement of dynein processivity. Overexpression of C-terminal-truncated Glued 
(GlΔ), known to dominantly block dynein/dynactin function, also resulted in axonal 
accumulation of dendritic Dscam, especially near the ends of axonal lobes (Figures 2-4A 
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and B, arrows).  These results indicate that normal dynein/dynactin function is essential 
for dendritic restriction of Dscam[TM1]::GFP.  Suppressing any component of 
dynein/dynactin complex may impede dynein/dynactin function and lead to the 
accumulation of Dscam[TM1]::GFP in axons. 
 
Blocking dynein/dynactin function does not affect dendritic targeting of two other 
dendritic markers 
 To determine how broadly dynein/dynactin is involved in dendritic protein 
targeting, we examined whether dynein/dynactin is required for proper localization of 
other dendritic proteins.  Several documented dendritic markers, including homer-GFP, 
Apc2-GFP, Act5C-GFP, Nod- β -gal and Rdl-HA (Sanchez-Soriano et al., 2005; Rolls et 
al., 2007), were ectopically expressed in the larval MBs using GAL4-201Y as the driver.  
In this condition, only Nod-β-gal and Rdl-HA showed predominant somatodendritic 
distribution and were largely excluded from MB axon lobes (Figures 2-4E and C; data 
not shown).   
 
 Nod-β-gal is a fusion protein comprised of the motor domain of Nod and β-
galactosidase, and has been shown to be a reliable minus-end reporter for microtubules in 
Drosophila, including MB neurons (Clark et al., 1997; Lee et al., 2000b; Reuter et al., 
2003).  Microtubules in MB dendrites are bi-directional, but uniformly oriented with 
plus-end pointing distally in axons.  Consistent with previous findings, Nod-β-gal was 
highly enriched in dendrites, cell bodies and proximal region of peduncles, but largely 
absent from distal region of peduncles and axonal lobes in wild-type MB neurons (Figure 
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2-4E).  Co-expression with dominant-negative Glued or ectopic induction in 
dynein/dynactin mutant clones (Lis1, Dmn and p24) did not alter its somatodendritic 
distribution (Figures 2-4F, 2-5B’-D’).  These results indicate that dynein/dynactin 
dysfunction did not perturb microtubule organization in axons, and that mistargeting of 
Dscam[TM1]::GFP did not occur as a consequence of abnormal microtubule polarity.   
 
 Rdl-HA (Resistant to Dieldrin) is a GABA receptor tagged with the HA epitope, 
and has been shown to be well restricted to dendrites in Drosophila embryonic motor 
neurons (Sanchez-Soriano et al., 2005).  In wild-type MB neurons, Rdl-HA was also 
localized in dendrites, cell bodies and proximal region of peduncles only (Figure 2-4C).  
Again, perturbation of dynein/dynactin function using dominant-negative Glued or by 
MARCM with Lis1, Dmn and p24 mutations did not alter the somatodendritic 
distribution of Rdl in the larval MBs (Figures 2-4D, 2-5F’-H’).  These results indicate 
that dynein/dynactin is selectively required for exclusion of dendritic Dscam from axons, 
implicating utilization of different mechanisms for restricting distinct membrane proteins 
to the dendrites. 
 
Retrograde transport plays a role in maintaining but not establishing Dscam[TM1] 
dendritic restriction 
 We wondered how dynein/dynactin complexes act to ensure restriction of 
Dscam[TM1] to the dendrites.  As a minus-end-directed microtubule motor, 
dynein/dynactin may actively move Dscam[TM1] from cell bodies to dendrites by 
selective transport.  Alternatively, it may play a scavenging role and constantly remove 
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mistargeted Dscam[TM1] out of axons via retrograde axonal transport (Burack et al., 
2000; Koonce and Samso, 2004; Pilling et al., 2006).  To distinguish between these two 
possibilities, we sought to visualize newly synthesized Dscam[TM1]::GFP and examine 
how dynein/dynactin dysfunction might affect the initial sorting of Dscam[TM1] and/or 
the maintenance of its dendritic distribution.  
 
 Transient induction of Dscam[TM1]::GFP in the larval MBs was achieved using 
the TARGET system, in which GAL4-dependent expression of UAS-transgene is acutely 
controlled by a temperature-sensitive GAL4 repressor, GAL80ts (McGuire et al., 2003).  
At 18℃, GAL4-OK107 was fully suppressed by GAL80ts (Figure 2-6A and C).  
Following inactivation of GAL80ts by shifting the organisms to higher temperatures (see 
Experimental Procedures), we could start to detect mCD8::GFP or Dscam[TM1]::GFP in 
young MB neurons (whose axons occupy core regions of axonal bundles and are weakly 
labeled by 1D4 mAb, Mitsuhiko et al., 2002) approximately one hour after induction.  
Since the enrichment of newly synthesized protein in young MB neurons were seen for 
both mCD8::GFP and Dscam[TM1]::GFP, this phenomenon could possibly result from 
the expression profile of GAL4-OK107 at the wandering larval stage or the difference in 
the intrinsic properties of newly derived MB neurons versus mature ones.  Notably, while 
mCD8::GFP was uniformly distributed (Figure 2-6D), newly synthesized 
Dscam[TM1]::GFP was consistently located to dendrites (Figure 2-6B).  These 
observations suggest involvement of selective transport in targeting Dscam[TM1] 
specifically to the dendrites.     
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 We next co-expressed dominant-negative Glued to determine how compromised 
dynein/dynactin function might affect the sorting of newly synthesized 
Dscam[TM1]::GFP.  Analogous transient co-induction did not alter the dendritic 
distribution of Dscam[TM1]::GFP (data not shown, similar to Figure 2-6E).  However, an 
acute prolonged induction revealed a requirement for dynein/dynactin in the continuous 
restriction of Dscam[TM1] to the dendrites (Figures 2-6F-H).  Organisms carrying both 
UAS-Dscam[TM1]::GFP and UAS- GlΔ were reared at 18℃ until the wandering larval 
stage when they were subjected to a half-hour heat shock at 38℃ followed by continuous 
incubation at 30℃.  Interestingly, starting around six hours after heat shock, 
Dscam[TM1]::GFP gradually misdistributed into the axons (Figure 2-6M).  
Dscam[TM1]::GFP was first detected in the proximal region of peduncles (Figure 2-6F), 
then present in the beginning of axonal lobes (Figure 2-6G), and, by12 hours after heat 
shock, located throughout the entire axon lobes (Figure 2-6H).  By contrast, in the 
absence of dominant-negative Glued, Dscam[TM1]::GFP remained restricted to the MB 
calyces even after 28 hours of continuous induction (Figures 2-6I-L).  These results 
indicate that the misdistribution was not due to excessive expression of 
Dscam[TM1]::GFP, but rather owing to disruption of dynein/dynactin function by 
dominant-negative Glued. 
 
 Two possible scenarios may underlie the time course of mislocalization.  First, 
several hours of continuous induction might be needed to express enough truncated 
Glued for blocking dynein/dynactin function.  Second, dynein/dynactin could be 
dispensable to the selective transport of Dscam[TM1] from cell bodies to dendrites, and 
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specifically involved in removing any mistargeted Dscam[TM1] out of the axons.  In this 
case, blocking dynein/dynactin function should not affect the initial dendritic targeting of 
Dscam[TM1]::GFP, but would compromise the ability of neurons to promptly move 
Dscam[TM1]::GFP from the axon ‘hillock’ back to the somatodendritic region.  
 
 To determine if such a protracted process of misdistribution occurred as a 
consequence of slow accumulation of dominant-negative Glued, we further examined 
how increasing the dosage of dominant-negative Glued affects the misdistribution 
process.  If induction of dominant-negative Glued was the rate-limiting factor, increasing 
the dosage of truncated Glued should accelerate the onset of mistargeting.  As the copy 
number of UAS- GlΔ transgene was increased to two and even three, we did not detect 
any change in the profile of the slow-onset, gradual accumulation of Dscam[TM1]::GFP 
in the MB axons (Figure 2-6M).  These results indicate that the level of dominant-
negative Glued was not limiting the misdistribution process.  Furthermore, it suggests 
that blocking dynein/dynactin function did not affect the initial dendritic targeting of 
Dscam[TM1], but rather disrupted the maintenance of no dendritic Dscam in axons. 
 
 
DISCUSSION 
 Multiple lines of evidence indicate that the dynein/dynactin complex has an 
important function in maintaining proper distribution of dendritic Dscam in MB neurons.  
First, mutations in three components (Lis1, Dmn and p24) of the dynein/dynactin 
complex were recovered based on mislocalization of dendritic Dscam through a 
MARCM-based genetic mosaic screen (Figures 2-2A-C).  Second, silencing other 
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components of the complex with RNAi also resulted in mistargeting of dendritic Dscam 
to axons (Figures 2-3B-G).  Third, disrupting dynein/dynactin function with dominant-
negative Glued reproduced the mislocalization phenotype (Figure 2-4B).  Further, newly 
synthesized Dscam[TM1] was preferentially targeted to dendrites (Figure 2-6B).  
Interestingly, compromising dynein/dynactin function did not affect the targeting from 
cell bodies to dendrites but disrupted the continuous exclusion of dendritic Dscam from 
axons (Figures 2-6E-H, and 2-6M).  Altogether, our findings show that dynein/dynactin 
normally acts through retrograde transport to prevent Dscam[TM1] from entering axons. 
 
 Acute induction by TARGET revealed two mechanisms underlying the dendritic 
distribution of Dscam[TM1].  Newly synthesized Dscam[TM1] was largely excluded 
from axons, suggesting directed dendritic targeting and the involvement of selective 
transport in the dendritic distribution of Dscam[TM1].  Though dynein/dynactin is 
essential for restricting Dscam[TM1] to dendrites, knocking down dynein/dynactin 
function did not disrupt the directed dendritic targeting.  This leads us to believe that 
dynein/dynactin is required for preventing dendritic Dscam from misdistributing into 
axons.  When dynein/dynactin function was compromised, newly synthesized 
Dscam[TM1] remained consistently targeted to dendrites but later leaked into axons.  
Dendritic Dscam gradually filled the axons; and it took about six hours for Dscam[TM1] 
to reach the axon termini.  This protracted process of mislocalization suggests that 
dendritic Dscam passively leaks into the axons, and that dynein/dynactin-mediated 
retrograde axonal transport normally acts to rapidly move leaked Dscam[TM1]-
containing vesicles out of the axons.  In summary, these phenomena not only demonstrate 
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a dynein-dynactin-independent mechanism of selective transport that preferentially 
targets Dscam[TM1]-containing vesicles to dendrites, but also implicate the involvement 
of retrograde axonal transport in preventing accumulation of Dscam[TM1] in axons.  
These two independent mechanisms act together to ensure restriction of dendritic Dscam 
to the dendrites. 
 
 Although the dynein/dynactin complex is essential for maintaining dendritic 
distribution of Dscam[TM1], our results do not reveal whether mislocalized 
Dscam[TM1] is on the plasma membrane or in vesicles inside the cytoplasm.  It is 
possible that dendritic Dscam passively leaks into axons either through membrane 
diffusion or mistargeting of vesicles.  Since blocking endocytosis with temperature-
sensitive shibire mutant showed no obvious effect on Dscam dendritic distribution (data 
not shown), we favor the model that dynein/dynactin acts to prevent axonal accumulation 
of Dscam[TM1] by actively moving mistargeted Dscam[TM1]-containing vesicles out of 
axons by retrograde axonal transport (Figure 2-7). 
 
 However, dynein/dynactin is not routinely needed for excluding dendritic proteins 
from the axons.  Since no biological process can be carried out with absolute fidelity, it is 
conceivable that dendritic molecules of most kinds may accidentally leak into the axons.  
Some salvage mechanism(s) should exist for actively clearing mislocalized molecules to 
prevent any significant accumulation in the wrong places.  Dynein/dynactin mediates 
retrograde axonal transport and can serve as a general mechanism for removing dendritic 
molecules out of axons.  Nonetheless, blocking dynein/dynactin function did not affect 
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the distribution of two other dendritic markers we checked.  Nod-β-gal is a reliable 
minus-end reporter of microtubules, and misdistribution of Nod-β-gal in MB axons has 
been shown in short stop mutant clones, in which microtubule polarity is perturbed 
(Reuter et al., 2003).  Absence of Nod-β-gal from the axons of dynein/dynactin mutant 
neurons demonstrates that the microtubules in axons remained uniformly polarized with 
minus ends pointing toward cell bodies, and rules out the possibility that dendritic Dscam 
became mislocalized due to abnormal microtubule organization.  As to Rdl-HA, which, 
like Dscam[TM1], is a membrane protein, a lack of effect on its somatodendritic 
distribution indicates that dynein/dynactin is selectively involved in preventing dendritic 
Dscam from leaking into the axons.  Diverse mechanisms may be utilized to efficiently 
clear different dendritic proteins in axons.  
 
 Regarding the mechanism(s) of selective transport, directed dendritic targeting 
apparently requires motor proteins that selectively move cargos toward the dendrites.  
Since dendrites, but not axons, carry microtubules with minus ends pointing away from 
cell bodies, potential candidates that underlie directed dendritic targeting include all 
minus-end-directed microtubule motors.  Notably, dynein/dynactin is dispensable to the 
initial dendritic targeting of Dscam[TM1] or the continuous dendritic restriction of Rdl, 
arguing against any critical role for minus-end-directed dynein/dynactin in transporting 
cargos into the dendrites.  Other microtubule motors that might support such directional 
movement include dendrite-specific plus-end-directed motors (e.g. KIF17 and KIF21B, 
Marszalek et al., 1999; Setou et al., 2000), though it remains mysterious how a plus-end-
directed motor can be well restricted to dendrites.  In theory, forward genetic mosaic 
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screens will ultimately allow us to uncover the diverse mechanisms of dendritic protein 
targeting.  Encouragingly, we have obtained mutants that exhibit different mislocalization 
phenotypes, further characterization of which should shed additional light on neuron 
polarity and its underlying cellular/molecular mechanisms.  Notably, in DC-B9 mutant 
clones, mistargeted Dscam[TM1]::GFP existed abundantly in the MB peduncle, 
preferentially accumulated at the end of the peduncle, but never extended into the axon 
lobes.  This intriguing phenotype suggests the `presence of distribution barriers not only 
in the beginning of axons but also at the junction between the proximal axon domain 
(peduncle) and the distal axon segment (lobe), and implies another possible mechanism 
for restricting Dscam[TM1] to the dendritic membrane. 
 
 Furthermore, the functional roles of each subunit of the dynein/dynactin complex 
have not been fully determined (reviewed in Schroer, 2004).  Although several studies of 
the dynein light chains in mammalian cells indicate that dynein subunits can be 
functionally specialized (Tai et al., 2001), studies in Drosophila show that strong loss-of-
function mutations in different dynein/dynactin subunits show extensive overlap in the 
resulting mutant phenotypes (Reuter et al., 2003; Whited et al., 2004).  Our data indicate 
that Lis1, Dmn, Glued, p24, p25, Dhc64C, Dhc62B, and Dlc90F all participate in the 
complete function of dynein/dynactin complex in maintaining dendritic distribution of 
Dscam.  This result supports the idea that all the dynein/dynactin subunits work together 
to fulfill its diverse functions, and loss of any subunits may result in different degrees of 
similar dynein/dynactin-dysfunctional phenotypes. 
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 With respect to Dscam targeting motifs, we have reported that the cytoplasmic 
juxtamembrane domain of Dscam may dictate its TM-dependent subcellular localization 
(Shi et al., 2007).  However, further structure-distribution analysis only allowed us to 
locate an axonal targeting motif to the cytoplasmic juxtamembrane region of TM2, 
leaving its dendritic targeting motif(s) still undetermined (unpublished results).  In 
addition, we could not determine using the same system whether any of the mutants 
recovered here also affects the axonal targeting of Dscam[TM2], since transgenic 
Dscam[TM2] becomes uniformly distributed upon overexpression following an 
analogous induction.  The involvement of multiple mechanisms in targeting specific 
Dscams to specific neuronal domains further supports the notion that Dscam isoform 
compositions in the dendrites versus axons of the same neurons need to be independently 
regulated, elucidation of the physiological significance of which promises to shed new 
light on how the brain develops and operates. 
 
 In summary, we have uncovered a scavenger mechanism for maintaining 
dendritic distribution of Dscam[TM1] and provide an in vivo model to study neuron 
polarity and differential protein targeting.  On top of the many known functions of 
dynein/dynactin  (including mitosis, vesicular transport, retrograde signaling, neuronal 
migration), dynein/dynactin helps restrict certain dendritic proteins to the somatodendritic 
domain of neurons by preventing them from spreading into the axons.  Notably, multiple 
independent mechanisms act together to locate Dscam[TM1] to dendrites; and diverse 
mechanisms are utilized to target different dendritic proteins to the dendrites. 
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Figure 2-1. Genetic mosaic screen for mutants with abnormal Dscam[TM1] 
distribution 
(A) Schemes of the genetic crosses of the screen.  The star represents a mutagenized 
chromosome.  (B) Schematic diagram of MB subcompartments.  (C-G’) Composite 
confocal images of MB neuroblast clones co-labeled with mCD8::RFP (red) and 
Dscam[TM1]::GFP (green).  As compared to the wild-type control (C) where transgenic 
Dscam was absent from axons, various mutant clones (D, E, F, and G) exhibited different 
Dscam mislocalization phenotypes. Note that mutations of group IV disrupted MB gross 
morphologies (G and G’) and were all mapped to the gene short-stop. Scale bar (here and 
in all figures) represents 20 µm.   
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Figure 2-2. Mistargeting of dendritic Dscam in Group I mutant clones 
MB clones of different complementation groups of group I.  Granular accumulation of 
Dscam[TM1]::GFP (green) in the MB lobes was observed in four of the six 
complementation groups, including Lis1, Dmn, p24 and DB-D10 (A-D, arrows).  In 
contrast, mistargeted Dscam preferentially accumulated in the peduncles of DC-B9 
mutant clones (E, arrow), while Dscam[TM1]::GFP was rather uniformly distributed in 
AC-E10 clones (F, arrows).   MB clones were co-labeled by mCD8::RFP (red).  Note the 
reduced dendritic region in Lis1 mutant clone (arrowhead).  
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Figure 2-3. Mistargeting of dendritic Dscam following depletion of various 
components of dynein-dynactin complex  
(A-G) Distribution of Dscam[TM1]::GFP in the larval MBs where a dynein/dynactin-
unrelated gene CG8446 (A) or various components of dynein/dynactin complex (B-G) 
were silenced by induction of RNAis with GAL4-OK107.  Dscam[TM1]::GFP was no 
longer restricted to the cell bodies and calyx, when dynein/dynactin components were 
knocked down (B-G, compared to A).  Note granular accumulation at the ends of axon 
lobes in [B] to [D] (arrowheads) versus uniform distribution in [E] to [G] (arrows).  
Double knockdown (H and I) showed more granular accumulation at the ends of axons 
than individual knockdowns (E-G) have.  (J) Schematic illustration of dynein/dynactin 
complex. The entire axonal lobes were outlined by dashed lines according to the 1D4 
mAb staining (red in A).
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Figure 2-4. Effects of dominant-negative Glued on dendritic protein targeting 
Larval MBs expressing various dendritic markers, including Dscam[TM1] (A and B), 
Rdl-HA (C and D) and Nod-β-gal (E and F), in the absence or presence of dominant-
negative Glued.   Note that dominant-negative Glued selectively affected the 
somatodendritic distribution of Dscam[TM1]::GFP (compare B to A), and that 
mislocalized Dscam[TM1]::GFP preferentially accumulated at the ends of lobes (arrows). 
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Figure 2-5. Axonal exclusion of Dscam[TM1], but not Nod or Rdl, requires 
dynein/dynactin 
Larval MB clones co-expressing Dscam[TM1]::GFP (A-D and E-H) with Nod-β-gal (A’-
D’) or Rdl-HA (E’-H’).  As compared to wild-type controls, Lis1, Dmn and p24 mutant 
clones had Dscam[TM1]::GFP, but not Nod-β-gal or Rdl-HA, mislocalized to the MB 
axons. 
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Figure 2-6. Retrograde transport plays a role in restricting Dscam[TM1]::GFP to 
the somatodendritic domain 
(A-D) Transient induction of UAS-Dscam[TM1]::GFP or UAS-mCD8::GFP by TARGET.  Prior 
to induction, GAL80ts fully suppressed the expression at a permissive temperature (A, C).  
Notably, one hour after heat-shock inactivation of GAL80ts, Dscam[TM1]::GFP was detected 
only in MB calyx (B) while mCD8::GFP distributed throughout the entire neurons (D).  (E-L) 
Induction of Dscam[TM1]::GFP with or without GluedDN.   Following co-induction with 
dominant-negative Glued, Dscam[TM1]::GFP gradually spread into MB peduncles and axonal 
lobes (F-H, arrows).  In contrast, Dscam[TM1]::GFP was well restricted to the MB calyx in the 
absence of dominant-negative Glued (I-L).  (M) Effects of GluedDN dosage on the 
misdistribution of Dscam[TM1]::GFP.  Dscam[TM1]::GFP could localize in dendrites only (e.g. 
[E]), dendrites plus peduncles (e.g. [F]), dendrites, peduncles plus proximal portions of axon 
lobes (e.g. [G]), or from calyx to the tips of axon lobes (e.g. [H]).  Note that increasing GlueDN 
dosage did not accelerate the mislocalization process.
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Figure 2-7. Multiple mechanisms govern the dendritic distribution of Dscam[TM1]  
Dscam[TM1]-containing cargos are primarily targeted to dendrites via a dynein/dynactin-
independent process.  In addition, they are effectively excluded from the axons by 
dynein/dynactin-mediated retrograde axonal transport. 
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ABSTRACT 
 Dscam, a member of the immunoglobulin superfamily of cell adhesion molecules, 
is involved in the neuronal morphogenesis in the Drosophila brain. Dscam generates 
thousands of isoforms through alternative splicing. The transmembrane (TM) domain of 
Dscam is encoded by exon 17, for which there are two alternative choices, exon 17.1 
(termed TM1) and exon 17.2 (termed TM2). Intriguingly, after pulse induction with the 
temporal and regional gene expression targeting (TARGET) system, Dscam[TM1] (full 
length Dscam with TM1 domain) and Dscam[TM2] (full length Dscam with TM2 
domain) can be targeted to dendrites and axons, respectively and separately, in 
Drosophila mushroom body (MB) neurons. Here we present structural and functional 
characterization of Dscam to examine the distribution of various mutant proteins, which 
allowed us to identify axonal and dendritic targeting motifs of Dscam. An axonal 
targeting motif has been identified in the cytoplasmic juxtamembrane portion of TM2, 
and two amino acids (1650Arg and 1654Asp) within this portion are essential for axonal 
targeting of Dscam. This axonal targeting motif is dominant over the dendritic targeting 
motif of Dscam, which is present in its ectodomain.  
 
INTRODUCTION 
 Neurons are highly polarized cells with two types of specialized extensions, 
dendrites and axons. Dendrites and axons require different sets of cell surface proteins 
(including receptors, ion channel and cell adhesion molecules) to achieve their distinct 
physiological functions (Craig et al., 1994). The mechanisms by which these distributions 
are established, maintained and modified are not well understood.  
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 Dscam is a Drosophila homolog of human Down syndrome cell adhesion 
molecule (DSCAM). Genomic and cDNA analyses demonstrates that Drosophila Dscam 
can generate tens of thousands of isoforms through alternative splicing in its exons 4, 6, 
9, 17, 19 and 23 (Schmucker et al., 2000; Wang et al., 2004). All the isoforms share a 
similar domain structure, with 10 immunoglobulin domains and 6 fibronectin type III 
repeats in the ectodomain, a single transmembrane (TM) domain and an endodomain. 
Dscam’s transmembrane domain is encoded by exon 17. There are two alternative 
choices for exon 17, exons 17.1 and 17.2. Previous studies in Drosophila mushroom 
body neurons have shown that ectopically expressed Dscam isoforms with exon 17.1 
(termed Dscam[TM1]) were preferentially localized to dendrites and cell body, while 
Dscam isoforms with exon 17.2 (termed Dscam[TM2]) were distributed throughout the 
entire neuron including axon, dendrites and cell bodies (Wang et al., 2004). The 
differential subcellular distribution of Dscam has important implications for the protein's 
function. Endogenous Dscam[TM1] and Dscam[TM2] primarily regulate dendritic 
elaboration and axonal arborization, respectively (Shi et al., 2007). Although 
physiological function of neuronal Dscam is likely to depend critically on the protein's 
locations in specific regions of neurons, little is known about the mechanisms responsible 
for this targeting process.  
 A key step in further defining mechanisms by which the differential distribution 
of a transmembrane protein is achieved is the identification of targeting motifs within the 
primary amino acid (aa) sequence of the protein that specify its subcellular localization. 
Multiple targeting motifs have been identified within several transmembrane molecules 
in neurons, including voltage-gated potassium channels, sodium channels, and 
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metabotropic glutamate receptors (West et al., 1997; Francesconi and Duvoisin, 2002; Gu 
et al., 2003; Garrido et al., 2001; Rivera et al., 2003). However, no targeting motifs of 
Dscam have been reported to date.  
 Constitutive overexpression of Dscam[TM2] by the traditional GAL4-UAS system 
showed no distribution preference in MB neurons. To better recapitulate the endogenous 
polarized distribution of Dscam[TM1] and Dscam[TM2], a temperature-sensitive GAL4 
repressor, GAL80ts was incorporated to acutely control the expression of UAS 
transgenes (McGuire et al., 2003). Through this system, we identified an axonal targeting 
motif in the cytoplasmic juxtamembrane portion of Dscam exon 17.2, which is dominant 
over a dendritic targeting motif located in the ectodomain of Dscam. Mutation of two 
amino acids (1650Arg and 1654Asp) in the axonal targeting motif can disrupt the axonal 
distribution pattern of Dscam[TM2]. The ectodomain of Dscam is sufficient to mediate 
dendritic targeting of membrane protein mCD8 in neurons. Furthermore, differential 
distribution of Dscam[TM1] and Dscam[TM2], which are coexpressed in the same MB 
neurons,  suggests the existence of a selective transport mechanism, which can recognize 
the targeting motifs of Dscam isoforms and transport them to distinct compartments in 
neurons.   
 
MATERIALS AND METHODS  
Fly stocks 
For acute induction by the TARGET system, we crossed UAS transgenes to tubP-
GAL80ts; tubP-GAL80ts; GAL4-OK107 (Yang et al., 2008). Other flies stocks used for 
this study include UAS-mCD8::RFP (Yang et al., 2008), UAS-mCD8::GFP, UAS-
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Dscam[TM1]::GFP, UAS-Dscam[TM2]::GFP (Wang et al., 2004), and UAS-Dscams 
with chimeric TMs (Shi et al., 2007).    
Constructs: 
Each Dscam construct was subcloned into the pUAST vector for P element-mediated 
germline transformation (Brand and Perrimon, 1993; Spradling and Rubin, 1982). For 
Dscam[TM1]::RFP, the monomeric red fluorescence protein (mRFP) open reading frame 
(Campbell et al., 2002) was amplified by PCR and was ligated in frame to the 3’ end of 
the full-length Dscam[TM1] cDNA (Wang et al., 2004) via a BamHI site. C-terminal 
truncated mutants of Dscam were generated by removing the coding sequence after the 
SacI site in exon 18. Chimeric mCD8-Dscam[TM1] and mCD8-Dscam[TM2] were 
constructed by replacing the Dscam ectodomain (amino acids 1-4772) with mCD8’s 
ectodomain (amino acids 1-194) through the introduction of a HindIII site between the 
mCD8 ectodomain and Dscam TMs. Chimeric Dscam-mCD8 was constructed by 
replacing the mCD8 ectodomain with Dscam’s ectodomain through the introduction of a 
PstI site between the Dscam ectodomain and mCD8 TM.   
Site-directed mutagenesis 
The full-length Dscam[TM2] cDNA (4.3-6.36-9.25-17.2+19+23, Wang et al., 2004) was 
digested with HindIII and SacI. The segment (4449 bp-5066 bp) containing exon 17.2 
was subcloned into pBluescript via HindIII and SacI sites. Mutations were introduced by 
site-directed mutagenesis following the protocol of the GeneTailerTM Site-Directed 
Mutagenesis (Invitrogen). Complementary mutagenesis primers were used to amplify the 
entire plasmid by polymerase chain reaction (PCR). This was followed by the digestion 
of the parental wild-type template with DpnI and the direct transformation into 
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Escherichia coli cells. The mutated plasmids were sequenced to ensure presence of the 
correct mutations, and then subcloned back into the full-length Dscam[TM2] cDNA.  
Acute Induction of UAS-transgenes by TARGET system 
Larvae carrying two copies of tubP-GAL80ts (McGuire et al., 2003) were cultured at the 
permissive temperature of 18°C beginning at embryo state in order to repress GAL4-
mediated transcription.  Wandering larvae were shifted to 38°C for 30 min, followed by 
incubation at the non-permissive temperature of 29°C for two hours.  
Immunohistochemical staining 
The central nervous systems from wandering third instar larvae were dissected out, fixed 
and immunostained as previously described (Lee and Luo, 1999). Protein expression was 
detected by the rabbit anti-GFP Ab (1:300, Molecular Probes) and MB lobes were labeled 
by the 1D4 mAb (1:80). Immunofluorescent signals were collected by confocal 
microscopy and then processed using Adobe Photoshop to normalize and exclude the 
background neurons. 
 
RESULTS 
Subcellular localization of GFP-tagged Dscam[TM1] versus Dscam[TM2]  
 Our previous studies suggested that Dscam[TM1] and Dscam[TM2] have separate 
functions in dendrites versus axons (Shi et al., 2007). According to constitutive 
overexpression data, Dscam[TM1] is preferentially localized in dendrites and cell bodies 
in Drosophila MB neurons, while Dscam[TM2] is uniformly distributed in axons, 
dendrites and cell bodies (Figure 3-1A and B). The inconsistency between the uniform 
distribution and specific function ofDscam[TM2] in axons raised a question whether 
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Dscam[TM2] may be preferentially expressed in axons in lower expression situations, 
which better mimic endogenous protein levels. In order to detect distribution of newly 
synthesized and low level expressed Dscam molecules, we adopted the TARGET system 
by incorporation of a temperature-sensitive GAL80 (GAL80ts) as a GAL4 repressor. By 
controlling the culturing temperature, we were able  to "turn off and on" the GAL4-UAS 
transgene expression and to observe Dscam protein distribution through 
immunofluorescence staining. Previously, we had shown that the TARGET system 
worked well in Drosophila mushroom body (MB) neurons (McGuire et al., 2004; Yang et 
al., 2008). Here we applied the TARGET system to Dscam[TM1]::GFP and 
Dscam[TM2]::GFP. Interestingly, after acute induction for 1.5 hours, Dscam[TM1] can 
only be detected in dendrites of MB (Figure 3-1C), and Dscam[TM2] is specifically 
localized to axons (Figure 3-1D). This result indicated that low level expression of 
Dscam molecules results in specific transportation of Dscam protein to dendrites or axons 
depending on which exon 17 is expressed. This differential distribution pattern of 
Dscam[TM1] and Dscam[TM2] is in keeping with the previous findings of their separate 
functional roles in dendrites versus axons.   
 Furthermore, because Dscam[TM1] and Dscam[TM2] can be transported to 
dendrites and axons respectively, we wondered whether the distribution preference of 
each would be affected if we coexpressed both in the same neurons. We tagged 
Dscam[TM1] with RFP, and coexpressed Dscam[TM1]-RFP with Dscam[TM2]-GFP in 
the same neurons with the TARGET system (Figure 3-1E). Interestingly, within the same 
neurons, Dscam[TM1] is still targeted to dendrites and Dscam[TM2] is transported to 
axons separately. This result suggested the existence of a sorting mechanism to separate 
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newly synthesized Dscam[TM1] and Dscam[TM2] into distinct vesicles which, in turn, 
are selectively transported to different destinations. Next, to confirm the polarized 
distribution of Dscam does not result from loss of axons or dendrites, we expressed 
mCD8-RFP to outline the entire neuron (Figure 3-1F). Coexpression of Dscam[TM1]-
GFP with mCD8-RFP showed that Dscam[TM1] was restricted to dendrites while mCD8 
was evenly distributed in axons, dendrites and cell bodies. This result indicates that 
dendritic distribution of Dscam[TM1] is mediated by a selective transport mechanism 
which may not play any role in the distribution of mCD8 protein. Taken together, these 
observations provide evidence for the involvement of a sorting and selective targeting 
mechanism in polarized distribution of Dscam in neurons.   
 
Dscam endodomain is not involved in axonal-dendritic distribution of Dscam 
 To examine whether the endodomain of Dscam plays a role in its differential 
distribution, we truncated different lengths of the carboxyl terminal domain of Dscam. 
Two truncations were generated by deleting the 105 and 342 amino acids from the C-
terminal end. Despite increased cell body accumulation of these truncated mutant 
proteins, these mutant proteins showed no effect on their dendritic or axonal distribution, 
depending on which exon 17 they carried (Figure 3-2A and B). The accumulation of 
truncated proteins in the cell bodies remains to be further examined, to determine whether 
these proteins were retained in ER, Golgi or localized in the cytoplasm. These results 
indicated that although truncation of the C-terminus of Dscam reduced the ability of 
Dscam proteins to be exported out of the cell body, it did not affect the polarized 
distribution of Dscam.  
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Dscam ectodomain contributes to dendritic targeting of Dscam 
 To examine whether the ectodomain of Dscam plays a role in its polarized 
distribution, we swapped the ectodomain of Dscam with the ectodomain of mCD8, which 
is used as a membrane marker without a distribution preference in Drosophila neurons 
(Lee et al., 1999; Yang et al., 2008). We generated two chimeric constructs, 
mCD8[TM1]::GFP (Figure 3-2C) and mCD8[TM2]::GFP (Figure 3-2D). Both chimeric 
proteins exhibited more cell body accumulation than Dscam[TM1]::GFP and 
Dscam[TM2]::GFP. However, outside the cell body regions, mCD8[TM1]::GFP was 
distributed evenly throughout the entire MB neuron including axons and dendrites; while 
mCD8[TM2]::GFP was still preferentially targeted to axons. Comparing the distribution 
patterns of mCD8[TM1]:: GFP and Dscam[TM1]-GFP raised the possibility that the 
Dscam ectodomain may carry a dendritic targeting motif. On the other hand, the axonal 
distribution pattern of mCD8[TM2]::GFP indicated that the Dscam ectodomain may not 
be involved in the axonal targeting of Dscam. 
 To confirm that the ectodomain of Dscam encodes a dendritic targeting motif, we 
replaced the ectodomain of mCD8 with the ectodomain of Dscam and generated a 
chimeric construct, Dscam-mCD8::GFP (Figure 3-2E). Intriguingly, Dscam-mCD8::GFP 
was preferentially transported to dendrites. This result suggested that the ectodomain of 
Dscam carries a dendritic targeting motif, which is sufficient to direct membrane proteins 
to neuronal dendrites.  
 
Mapping the targeting motifs in exon17.1 and exon17.2 of Dscam  
53 
 
 Because the difference in amino acid sequences between Dscam[TM1] and 
Dscam[TM2] is the alternative exon 17, we postulated the existence of targeting motifs in 
exon 17.1 or exon 17.2. Exon 17.1 and 17.2 encode single transmembrane domains and 
two juxtamembrane segments in extracellular and cytoplasmic regions (Figure 3-3A). 
The protein sequences of exon 17.1 and exon 17.2 share 80% similarity in their 
transmembrane domains, 33% similarity in the extracellular juxtamembrane segments 
and 35% similarity in the cytoplasmic juxtamembrane segments. To identify the targeting 
motifs in exons 17, we swapped the counterparts of juxtamembrane portions between 
exon 17.1 and exon 17.2 and expressed in MB neurons (Figure 3-3A).  Intriguingly, the 
chimeric proteins Dscam[17.1/17.2] (Figure 3-3B) and Dscam[17.2/17.1] (Figure 3-3C) 
exchanged their distribution preferences. The chimeric protein with the cytoplasmic 
juxtamembrane segment from exon 17.2 and the remaining parts from exon 17.1 was 
transported to axons, while the chimeric protein carrying the cytoplasmic juxtamembrane 
segment from exon 17.1 and the remaining parts from exon 17.2 was targeted to 
dendrites. These results indicated that the cytoplasmic juxtamembrane portions of exons 
17 are important in the polarized distribution of Dscam[TM1] and Dscam[TM2].   
 In comparison between the juxtamembrane domains of 17.1 and 17.2 (Figure 3-
3A), we found that there was an additional RRRADDMR segment in 17.2, which is 
absent from 17.1. To determine which amino acids in this region are involved in axonal 
targeting of Dscam[TM2], we conducted site-directed(scanning) alanine mutagenesis. 
Several mutants were generated and their protein distribution was examined with 
transient induction, including 17.2[AAAADDMR] (3-3D), 17.2[RRAAAAA] (3-3E), 
17.2[RARADDMR] (3-3F), 17.2[RRAADDMR] (3-3G), 17.2[RRRAAAMR] (3-3H), 
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17.2[AAAAADMR] (3-3I). Taken together, we found that the second Arginine (1650aa) 
and the second Aspartate (1654aa) are essential for axonal targeting of Dscam[TM2]. 
Mutations of either one to alanine caused partial mislocalization of Dscam[TM2] to 
dendrites.  
 
DISCUSSION 
 Neurons are one of the most highly polarized cell types. Polarized distribution of 
distinct cell surface molecules in different compartments underlies most aspects of their 
physiological functions. The molecular bases for differential sorting and trafficking of 
these membrane proteins are still being uncovered. Most of our current understanding 
about sorting and trafficking mechanisms comes from studying Madin-Darby Canine 
Kidney (MDCK) epithelial cells. It is evident that some of the signals and the machinery 
involved in polarized distribution are conserved between epithelial cells and neurons 
(Dotti and Simons, 1990), but cell-type specific mechanisms have also been described 
(Silverman et al., 2005). Similarities between dendritic targeting in neurons and 
basolateral targeting in epithelial cells have been suggested by experiments (Matter et al., 
1994; Odorizzi and Trobridge, 1997; West et al, 1997).  However, sorting to the apical 
and axonal compartments is less well understood.    
 Recent studies confirmed that peptide motifs mediate polarized targeting of 
membrane proteins in neurons (reviewed by Arnold, 2007). Several dendritic and axonal 
targeting motifs have been identified. For instance, a dileucine-containing motif in 
potassium channel Kv4.2 and tyrosine-based motifs found in neuroligin-1, transferrin 
receptor and nicotinic acetylcholine receptors have been shown to mediate dendritic 
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targeting (Rivera et al., 2003; West et al., 1997; Silverman et al., 2005; Xu et al., 2006). 
In addition, a dileucine-containing motif of Nav1.2, a leucine-cotaining motif in nicotinic 
acetylcholine receptors, a tripeptide RRK in mGluR1b, and a T1 tetramerization domain 
in Kv1 have been determined to act as axonal targeting signals (Garrido et al., 2001; Gu 
et al., 2003; Rivera et al., 2005; Xu et al., 2006). It is well documented that both dendritic 
and axonal proteins rely on short amino acid sequences within their cytoplasmic tails for 
polarized sorting. In our results, the dendritic targeting motif of Dscam is located in the 
ectodomain. How could a motif in an ectodomain be recognized by the sorting machinery 
while it is embedded inside a vesicle? One possibility is that Dscam interacts with 
another protein through its ectodomain to achieve its dendritic sorting. A similar 
phenomenon can be observed for axonal targeting of Kv1, which depends on another 
protein, Kvβ, that interacts with Kv1 through its T1 domain. In addition, the axonal 
targeting motif of Dscam located in the cytoplasmic juxtamembrane domain of TM2 
bears no similarity to other identified axonal targeting motifs. This suggests that the 
axonal targeting of Dscam[TM2] could be mediated by novel targeting mechanisms.  To 
define the targeting mechanisms of Dscam, the identification of proteins that bind to 
targeting motifs will make it possible to determine whether other polarized proteins share 
a common targeting mechanism. 
 Polarized distribution of exogenous proteins has been shown in Drosophila 
neurons (Rolls et al., 2007). However, one difficulty in analyzing the distribution of 
tagged exogenous proteins in Drosophila neurons is the loss of localization when the 
expression level is much higher than the endogenous level. To reduce the expression 
level of exogenous proteins, Rolls et al., used different approaches including raising 
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larvae at 18℃, reducing the number of UAS sequences from five to two, and using 
certain lowly expressed GAL4 lines. In our study, we  incorporated the TARGET system 
to detect the polarized distribution of newly synthesized proteins at very low expression 
levels. In the constitutively overexpressed situation, Dscam[TM1]::GFP was localized to 
dendrites and cell bodies of MB neurons while Dscam[TM2]::GFP was distributed 
throughout the entire neurons. In the acute induction with the TARGET system, newly 
synthesized Dscam[TM1] was only detected in dendrites, and Dscam[TM2] was 
localized to axons. This result demonstrated that TARGET will be a powerful system to 
study the polarized distribution of exogenous proteins in vivo.  
 Through TARGET, we identified an axonal targeting motif of Dscam and showed 
that two residues (1650Arg and 1654Asp) are involved in axonal targeting. Furthermore, 
we suggest a polarized sorting and targeting mechanism exists in MB neurons because 
Dscam[TM1] and Dscam[TM2] were targeted to dendrites and axons separately when 
coexpressed in the same neurons simultaneously. It would be interesting to conduct a 
genetic screen in MB neurons to identify mutants which disrupt the polarized distribution 
of Dscam. Through this, we can further elucidate how neurons create and maintain the 
complex expression patterns of polarized proteins.  
Taken together, this study provides four important new findings: (1) dendritic targeting of 
Dscam relies on its ectodomain; (2) an axonal targeting motif of Dscam is located in the 
cytoplasmic juxtamembrane region of TM2, which is dominant over the dendritic 
targeting motif; (3) a polarized sorting mechanism exists in Drosophila MB neurons; and 
(4) TARGET is a good system to study polarized targeting mechanisms of proteins in 
vivo. 
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Figure 3-1. Polarized distribution of Dscam[TM1] and Dscam[TM2] in Drosophila 
MB neurons.   
(A-B) Constitutive overexpression of Dscam[TM1]::GFP (A) and Dscam[TM2]::GFP (B) 
with GAL4-OK107.  
(C-D) Transient induction of Dscam[TM1]::GFP (C) and Dscam[TM2]::GFP (D) with 
GaL4-OK107 using the TARGET system. In contrast to constitutive overexpression 
results, Dscam[TM1] was specifically targeted to dendrites and Dscam[TM2] was only 
detected in axons.  
(E) Transient induction of both Dscam[TM1]::RFP and Dscam[TM1]::GFP  in the same 
MB neurons. Coexpression of Dscam[TM1] and Dscam[TM2] did not interfere with their 
individual polarized targeting.  
(F) Transient induction of both Dscam[TM1]::GFP and mCD8::RFP  in the same MB 
neurons. mCD8 showed no distribution preference. 
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Figure 3-2. Dscam ectodomain carries a dendritic targeting signal. 
(A-B) Transient induction of cytoplasmic truncation mutants of Dscam[TM1]Δ::GFP (A) 
and Dscam[TM2]Δ::GFP (B). Deletion of Dscam endodomain did not affect the 
polarized distribution patterns between dendrites and axons. Instead, truncation resulted 
in more accumulation in cell bodies. 
(C-D) Transient induction of chimeric transgenes mCD8[TM1]::GFP (C) and 
mCD8[TM2]::GFP (D). mCD8[TM1] was distributed uniformly in MB neurons. 
mCD8[TM2] was localized in axons and cell bodies, but less in dendrities. 
(E) Transient induction of chimeric transgene Dscam-mCD8::GFP. Dscam ectodomain 
carries a dendritic targeting signal which is sufficient to localize the chimeric protein to 
dendrites only. 
(F) Transient induction of mCD8::GFP.  
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Figure 3-3. An axonal targeting motif of Dscam is located in the cytoplasmic 
juxtamembrane portion of TM2 
(A) A diagram shows the amino acid sequences of TM1 and TM2. Swapping the 
cytoplasmic juxtamembrane portions between TM1 and TM2 generates two chimeric TM 
constructs: Dscam[17.2/17.1]::GFP and Dscam[17.1/17.2]:GFP.  
(B-C) Transient induction of Dscam[17.1/17.2]::GFP (B) and Dscam[17.2/17.1]::GFP 
(C). After swapping the cytoplasmic juxtamembrane portions, the polarized distribution 
patterns were exchanged.  
(D-I) Site-directed mutagenesis was used to mutate different amino acids in the axonal 
targeting motif to alanines. Transient induction of these mutant Dscam[TM2]::GFP 
constructs: 17.2[AAAADDMR] (D), 17.2[RRRAAAAA] (E), 17.2[RARADDMR] (F), 
17.2[RRAADDMR] (G), 17.2[RRRAAAMR] (H) and 17.2[AAAAADMR] (I). Mutated 
amino acids are colored in red in the diagram and underlined in the legend.  
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Chapter 4 
 
Specific Drosophila Dscam juxtamembrane variants control dendritic 
elaboration and axonal arborization 
 
 
 
 
 
 
 
The following work is reprinted from the Journal of Neuroscience article of the same 
name published as: 
 
Lei Shi*, Hung-Hsiang Yu*, Jacob Shun-Jen Yang* and Tzumin Lee. J. Neurosci, 20 
June 2007: Vol. 27. No.25, pp. 6723-6728. 
 
*These authors contributed equally to this study 
61 
 
ABSTRACT 
 Drosophila Dscam isoforms are derived from two alternative transmembrane/ 
juxtamembrane domains (TMs) in addition to thousands of ectodomain variants. Using a 
microRNA-based RNA interference technology, we selectively knocked down different 
subsets of Dscams containing either the exon 17.1- or exon 17.2-encoding TM. 
Eliminating Dscam[TM1] reduced Dscam expression but minimally affected 
postembryonic axonal morphogenesis. In contrast, depleting Dscam[TM2] blocked axon 
arborization. Further removal of Dscam[TM1] enhanced the loss-of-Dscam[TM2] axonal 
phenotypes. However, Dscam[TM1] primarily regulates dendritic development, as 
evidenced by the observations that removing Dscam[TM1] alone impeded elaboration of 
dendrites and that transgenic Dscam[TM1], but not Dscam[TM2], effectively rescued 
Dscam mutant dendritic phenotypes in mosaic organisms. These distinct Dscam functions 
can be attributed to the juxtamembrane regions of TMs that govern dendritic versus 
axonal targeting of Dscam as well. Together, we suggest that specific Drosophila Dscam 
juxtamembrane variants control dendritic elaboration and axonal arborization. 
 
INTRODUCTION 
 The insect Dscam gene encodes thousands of distinct immunoglobulin/ 
fibronectin-type cell adhesion molecules that mainly differ in their extracellular domain 
and can carry one of the two well-conserved transmembrane/juxtamembrane segments 
(TMs) (Schmucker et al., 2000). The variations in the ectodomain have drastic impacts on 
the inter-Dscam binding in vitro (Wojtowicz et al., 2004), whereas distinct TMs may 
target Dscam to different subcellular compartments (Wang et al., 2004; Zhan et al., 2004). 
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Such a huge repertoire of diverse homophilic cell adhesion molecules may help govern 
how a complex nervous system is specifically wired. 
 In Drosophila, Dscam is widely required for proper neuronal morphogenesis, 
especially the bifurcation/arborization of neurites. Interestingly, loss of Dscam function 
affects neurite trajectories selectively at the loci where bifurcation normally occurs 
(Wang et al., 2002; Chen et al., 2006). Some Dscam mutant neurites stall with clumps of 
possibly numerous short branches at the ends, resulting in truncation of axonal trees at 
their first points of bifurcation. These characteristic phenotypes are probably derived from 
excessive repetitive bifurcations of mutant growth cones, because others that have fully 
extended frequently exhibit evidence for additional bifurcations at the normal branching 
points. In addition, proper guidance of individual growth cones at the points of 
ramification, especially with respect to their sister growth cones, requires Dscam. It 
appears that Dscam controls neurite arborization by preventing comigration of sister 
growth cones, thus preventing the number of sister growth cones from exceeding the 
number of available fascicles. Dynamic stochastic expression of distinct Dscam 
ectodomains (Neves et al., 2004) would permit self recognition in such "like-kill-like" 
morphogenetic processes. Consistent with this model, most Dscam ectodomain exon 
alternatives are not conserved through evolution, arguing that the overall diversity is more 
critical than the identities of individual variants (Graveley et al., 2004). 
 In contrast, the two exon alternatives that encode the TM of Dscam are well 
conserved (Graveley et al., 2004). Interestingly, ectopic Dscam can be preferentially 
localized to dendrites by selective utilization of exon 17.1 (encoding TM1) or localized to 
axons by using exon 17.2 (encoding TM2) (Wang et al., 2004). To determine the roles of 
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Dscam[TM1] versus Dscam[TM2], we previously created Dscams lacking either exon 
17.1 or exon 17.2. Deletion of either exon 17 led to skipping of the other exon 17 in many 
Dscam transcripts (our unpublished results). Manipulating genomic Dscam can be 
problematic for other reasons (see Discussion). We, thus, resorted to a 
microRNA(miRNA)-based RNA interference (RNAi) technology (Chen et al., 2007) for 
specifically silencing exon 17.1- or exon 17.2-containing Dscam transcripts. We found 
that endogenous Dscam[TM1] and Dscam[TM2] primarily act to mediate dendritic 
elaboration and axonal arborization, respectively. Consistent results were obtained with 
transgenic Dscam alleviating dendrite versus axon phenotypes in Dscam mutant clones 
depending on the nature of its TM. In addition, the cytoplasmic juxtamembrane regions of 
the TMs are sufficient to control Dscam localization as well as its differential roles in 
dendrites versus axons. Together, we suggest that Dscams with distinct TMs control 
dendritic elaboration versus axonal arborization. 
 
MATERAILS AN METHODS 
Transgenes 
Standard molecular biological techniques were used to generate UAS-17.1 miRNA, UAS-
17.2 miRNA, and UAS-18 miRNA, which encode microRNAs carrying unique Dscam 
sequences derived from exon 17.1, exon 17.2, and exon 18, respectively. The complete 
nucleotide sequences of the microRNA constructs are in the appendix. In addition, the 
two UAS-Dscams with chimeric TMs were constructed by swapping the cytoplasmic 
juxtamembrane segment of TM1 (amino acid 1631-1648) with the cytoplasmic 
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juxtamembrane segment of TM2 (amino acid 1645-1661) through the introduction of an 
AccI site between the transmembrane and cytoplasmic juxtamembrane regions. 
Flies  
Transgenic flies carrying various UAS-miRNA and UAS-Dscam with chimeric TM were 
obtained by P element-mediated germ line transformation with technical support from 
Genetic Services. 
Tissue-specific induction of RNAi and phenotypic analysis by 
immunohistochemistry  
Targeted induction of UAS-miRNA involved use of various tissue-specific galactosidase-4 
(GAL4) drivers, and their phenotypic analysis mainly involved coexpression of various 
upstream activation sequence (UAS)-reporter genes. Both flip-out-marked clones of 
ellipsoid body (EB) neurons and MARCM (mosaic analysis with a repressible cell 
marker)-labeled clones of projection neurons (PNs) were induced in newly hatched larvae 
by heat shock for 40 min at 37°C. Whole fly brains were prepared for immunostaining as 
described previously (Lee et al., 1999). Detection of endogenous Dscam proteins 
involved a mouse monoclonal antibody (mAb) that was raised against the peptide 
ATLDKRRPDLRDELG. The anti-Dscam mAb, 1D4 mAb, and anti-mCD8 mAb were 
used at 1:20, 1:50, and 1:100, respectively. Fluorescence signals were captured with 
confocal microscopy and processed using Adobe Photoshop (Adobe Systems, San Jose, 
CA). 
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RESULTS 
microRNA-based RNA interference permits selective depletion of Dscam[TM1] 
versus Dscam[TM2] 
 Transgenic Drosophila Dscams with distinct TMs are enriched in dendrites or 
axons (Wang et al., 2004) and, consistent with such differential protein targeting 
phenomena, potently affect different aspects of neuronal morphogenesis (Wang et al., 
2004; Zhan et al., 2004). To determine whether endogenous Dscam with TM1 versus 
TM2 indeed helps govern different neuronal morphogenetic processes, we examined 
whether and how targeted depletion of Dscam[TM1] or Dscam[TM2] perturbs distinct 
aspects of neuronal morphogenesis in intact Drosophila brains. We first explored whether 
one can effectively knock down Dscam[TM1] versus Dscam[TM2] by specifically 
silencing the Dscam transcripts that carry exon 17.1 or exon 17.2 using a miRNA-based 
RNAi technology (Chen et al., 2007). We engineered three UAS-miRNA constructs, UAS-
17.1 miRNA, UAS-17.2 miRNA, and UAS-18 miRNA, to specifically target the Dscam 
exon 17.1, exon 17.2, and exon 18 (a common Dscam exon), respectively. For each UAS-
miRNA transgene, we identified the most potent transgenic line from multiple 
independent transformants by individually assaying its ability to antagonize GAL4-
induced coexpression of UAS-Dscam::GFP (green fluorescent protein). We resorted to 
transgenic Dscam::GFP, because direct visualization of Dscam[TM1] versus 
Dscam[TM2] was not possible without antibodies against different TMs. Pairing 
transgenic miRNA with Dscam::GFP that carries the miRNA target sequences 
consistently led to a drastic reduction in the level of Dscam-GFP expression (Figure 4-
S1C and F). In contrast, even with the most potent transgenic line, UAS-17.1 miRNA and 
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UAS-17.2 miRNA exerted no detectable effect on the alternative isoform (Figure 4-S1D 
and E). It assures no cross-reactivity, also eliminating the trivial explanation that 
suppression of Dscam transgenes might result from the presence of multiple UAS 
transgenes. These observations provide us with the opportunity to use transgenic miRNA 
to knock down specific subsets of Dscam isoforms in intact fly brains. 
 We then examined how a broad induction of various Dscam-targeted miRNAs 
affects the endogenous Dscam expression in the developing Drosophila CNS. We could 
normally detect abundant Dscam proteins in the larval neuropils by immunostaining with 
a peptide antibody against some Dscam common motif(s) (Wang et al., 2004) (Figure 4-
1A). Interestingly, such Dscam immunoreactivity was differentially abolished after pan-
neuronal induction of various miRNA transgenes. First, we were encouraged by the lack 
of detectable residual Dscam after induction of UAS-18 miRNA (Fig. 4-1B) or 
coinduction of UAS-17.1 miRNA and UAS-17.2 miRNA (Figure 4-1C), which are both 
expected to silence all Dscam splice variants. Second, induction of UAS-17.1 miRNA or 
UAS-17.2 miRNA alone, even in multiple copies, left its overall pattern of expression 
essentially unchanged (Figure 4-1D and E). Depleting Dscam[TM1] versus Dscam[TM2] 
should provide insight into the spatial/temporal patterns of TM1 versus TM2 expression. 
Interestingly, close inspection revealed that Dscam[TM1] apparently exists more 
abundantly than Dscam[TM2] in the larval CNS, especially within the abdominal 
ganglion (Figure 4-1, compare D with E). Together, these observations demonstrate the 
general feasibility of knocking down Dscam[TM1] versus Dscam[TM2] using UAS-17.1 
miRNA or UAS-17.2 miRNA. Additionally, both UAS-18 miRNA alone and UAS-17.1 
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miRNA plus UAS-17.2 miRNA should allow us to determine the Dscam "null" phenotypes 
one can obtain with various GAL4 drivers. 
  
Dscam[TM2], but not Dscam[TM1], plays an essential role in governing axon 
arborization, probably because of differential protein targeting 
 To determine the roles of Dscam[TM1] versus Dscam[TM2] in Dscam-dependent 
axonal morphogenesis, we first examined how expression of specific Dscam-targeted 
miRNAs affects the morphogenesis of mushroom body (MB) axons. Transgenic miRNA 
was induced through MB development using GAL4-OK107. We selectively focused on its 
effects on the orthogonal and ß lobes, because they are normally derived via Dscam-
governed axon bifurcation, and one can readily identify the MB /ß axons based on their 
strong immunoreactivity with the 1D4 monoclonal antibody (Wang et al., 2002). 
Interestingly, induction of UAS-18 miRNA or UAS-17.2 miRNA alone, but not UAS-17.1 
miRNA, drastically disrupted the formation of /ß lobes (Figure 4-2). Abnormal /ß lobes 
were often misshapen and variably truncated (Figure 4-2B–E), reminiscent of the 
deformed MBs in Dscam mutant organisms (Wang et al., 2004). This suggests 
involvement of Dscam[TM2], but not Dscam[TM1], in MB axonal morphogenesis. We 
further classified the anomalies based on the presence or absence of any /ß lobe residue 
and its degree of extension (severe, no /ß neurite extended beyond the peduncle terminus; 
strong, no neurite reached the tips of /ß lobes; medium, small subsets of /ß neurites were 
fully extended; weak, grossly intact lobes failed to segregate). Quantitative analysis of the 
above phenotypes (n > 100, each) revealed that UAS-17.2 miRNA alone did not cause as 
much of a defect as UAS-18 miRNA (Figure 4-2I) (5.0 ± 2.0 vs 52.7 ± 4.5% for the severe 
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phenotype). This is apparently a result of the possibility that endogenous Dscam[TM1] 
could partially compensate for the loss of Dscam[TM2] in the Dscam-governed 
bifurcation of MB axons, because doubling the dosage of UAS-17.2 miRNA did not 
enhance the phenotypes (8.7 ± 2.5%), but coinduction of UAS-17.1 miRNA and UAS-17.2 
miRNA fully recapitulated the 18 miRNA-derived null phenotypes (59.0 ± 6.0%) (Figure 
4-2I). Together, these results provide direct evidence for differential involvement of 
Dscam[TM1] and Dscam[TM2] in supporting neuronal morphogenesis. 
  
 Preferential usage of exon 17.2 over exon 17.1 might explain why Dscam[TM2] 
plays a dominant role in this particular developmental event. To rule out this possibility, 
we attempted to rescue the 18 miRNA-derived null phenotypes by supplementing 
transgenic Dscam[TM1] or Dscam[TM2]. We reasoned that both Dscam transgenes carry 
wild-type exon 18 and should be suppressed by 18 miRNA to an analogous degree, if 
they were comparably induced. Additionally, their ability to antagonize silencing of 
endogenous Dscam by 18 miRNA should be identical. Thus, any difference in their 
rescue of 18 miRNA-derived loss-of-Dscam phenotypes can be ascribed to the presence 
of TM1 or TM2 in the comparably residual transgenic Dscam. We previously identified 
UAS-Dscam::GFPs that exhibit similar levels of induction (Wang et al., 2004). Using 
these lines, we obtained substantially better rescue after coinduction of UAS-18 miRNA 
with UAS-Dscam[exon 17.2]::GFP than with UAS-Dscam[exon 17.1]::GFP (Figure 4-2I) 
(38.0 ± 1.8 vs 6.9 ± 0.4% for the weak plus normal phenotypes). This supports the notion 
that Dscam[TM2] and Dscam[TM1], which differ only in the TMs, are functionally 
distinct. To locate the structural basis for such a functional distinction between 
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Dscam[TM1] and Dscam[TM2], we conducted structural-functional analysis and 
generated two chimeric TMs by swapping the cytoplasmic juxtamembrane portions 
between TM1 and TM2 (Figure 4-2F). Interestingly, this exchange reversed the 
functional distinction (Figure 4-2I) (rescued to 69.0 ± 3.0% with 17.1/17.2 vs 7.3 ± 2.4% 
with 17.2/17.1) as well as their differential protein targeting between Dscam[TM1] and 
Dscam[TM2] (Figure 4-2G and H). These results suggest that the cytoplasmic 
juxtamembrane domains of Dscam govern its TM-dependent differential subcellular 
localization and further imply that, probably because of differential targeting, TM2-
containing Dscam isoforms function primarily in axons, whereas TM1-containing 
Dscams possibly act in dendrites within neurons. 
 To examine whether Dscam[TM2], but not Dscam[TM1], is broadly used to 
mediate diverse axonal morphogenesis, we further investigated whether and how 
knocking down Dscam[TM1] or Dscam[TM2] levels affects the morphogenesis of EB 
neurons. We reported previously that Dscam-dependent proper arborization of axons is 
also required for full elaboration of EB neurites in the centrally placed EB neuropil 
(Wang et al., 2002). Interestingly, after separate induction of UAS-17.1 miRNA and UAS-
17.2 miRNA using asense-GAL4 (Zhu et al., 2006b) plus GAL4-EB1 (Wang et al., 2002), 
only UAS-17.2 miRNA could phenocopy the morphogenetic defects characteristic of 
Dscam mutant EB neurons (Figure 4-S2A–D) (100%; n = 10, each). This observation 
again supports the notion that Dscam[TM2], but not Dscam[TM1], plays an essential role 
in governing diverse axonal morphogenetic processes, and, as addressed above, this 
difference in function is probably derived from differential protein targeting. 
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Dscam[TM1] is involved primarily in dendritic elaboration 
 Transgenic Dscam[TM1]::GFP is selectively enriched in dendrites in diverse 
model neurons, including the antennal lobe (AL) PNs (Wang et al., 2004). To determine 
whether Dscam[TM1] is preferentially involved in dendritic morphogenesis, we resorted 
to PNs for additional analysis of the TM-dependent distinct Dscam morphogenetic 
functions. In contrast with MB and EB neurons where Dscam appears dispensable for 
dendritic morphogenesis (Wang et al., 2002), the PNs, especially the ventral lineage-
derived multiglomeruli-targeting PNs (in the vPN clones), require Dscam for full 
elaboration of their dendrites in the ALs in addition to proper arborization of their axons 
in the lateral horns (LHs) (Zhu et al., 2006a). 
 We first demonstrated that GAL4-GH146-dependent induction of UAS-18 miRNA 
in the otherwise wild-type vPN neuroblast (Nb) clones potently suppressed the 
elaboration of MARCM-labeled dendrites in the ALs and disrupted their axonal 
arborization in the LHs (Figure 4-3D, H and L) (100%; n = 10). The dendrites of 
multiglomeruli-targeting PNs became aberrantly restricted to the AL medial upper 
portion where the axon passage resides (Figure 4-3H, arrow). In the LHs, their axonal 
branches failed to extend away from one another and often stalled with abnormal 
aggregates (Figure 4-3L, arrow). In addition, the projection out of the LH (Figure 4-3I 
and J, arrowheads) is essentially missing. These morphogenetic defects are analogous to 
the previously documented Dscam loss-of-function PN phenotypes (Zhu et al., 2006a). 
We then wondered whether depleting Dscam[TM1] versus Dscam[TM2] in the same 
neurons might differentially affect the morphogenesis of their dendrites versus axons. 
UAS-17.1 miRNA and UAS-17.2 miRNA were separately induced by GAL4-GH146 in 
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the vPN Nb clones. Remarkably, the loss-of-Dscam dendritic and axonal phenotypes 
were uncoupled and well correlated with the protein targeting phenomena. Induction of 
UAS-17.1 miRNA alone effectively suppressed PN dendritic elaboration but minimally 
affected their axonal arborization (Figure 4-3B, F and J) (100%; n = 9). In contrast, 
induction of UAS-17.2 miRNA alone selectively disrupted the arborization of PN axons 
in the LHs (Figure 4-3C, G and K) (100%; n = 15). We further quantified dendrite 
phenotypes by counting the glomeruli that became not innervated by GAL4-GH146-
positive PNs in the above vPN Nb clones. Given the presence of several GAL4-GH146-
positive pan-glomerular PNs in the vPN lineage, there is normally no glomerulus where 
we could not detect any vPN-lineage-derived GAL4-GH146-labeled neurites. Such vPN 
dendrites were also fully elaborated after depletion of endogenous Dscam[TM2], as 
revealed by no GAL4-GH146-unlabeled glomerulus despite induction of 17.2 miRNA. In 
contrast, depleting endogenous Dscam[TM1] with 17.1 miRNA made a significant and 
comparable number of AL glomeruli devoid of MARCM-labeled vPN dendrites as 
knocking down all Dscam isoforms by 18 miRNA (17.1, 10.86 ± 0.69 vs 18, 11.00 ± 
0.82). These results collectively suggest that differential protein targeting of 
Dscam[TM1] and Dscam[TM2], respectively, controls dendritic elaboration and axonal 
arborization. 
  
 Consistent with this notion, single-ectodomain transgenic Dscam significantly 
rescued certain Dscam mutant phenotypes in dendrites versus axons, depending on the 
presence of TM1 or TM2. Briefly, using two distinct Dscam transgenes that differ only in 
their exon 17, we had shown previously that transgenic Dscam[TM2], but not 
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Dscam[TM1], could effectively rescue various axonal morphogenetic defects in single-
cell clones of Dscam mutant MB neurons (Wang et al., 2004). Interestingly, when the 
same pair of Dscam transgenes were respectively examined for its effects on Dscam 
mutant DL-1 PNs, we found that PN dendrite defects were rescued only by transgenic 
Dscam[TM1], whereas only transgenic Dscam[TM2] partially rescued PN bouton 
formation in the MB calyces (Figure 4-4). This provides RNAi-independent evidence for 
involvement of Dscam[TM1] and Dscam[TM2] in the morphogenesis of dendrites and 
axons, respectively. 
 
DISCUSSION 
 Our use of an miRNA-based RNAi technology permits depletion of distinct 
subsets of Dscam isoforms based on their exon compositions. Reducing TM1-containing 
(encoded by exon 17.1) versus TM2-containing (encoded by exon 17.2) Dscams during 
morphogenesis of various model neurons allowed us to demonstrate that Dscam[TM1] 
and Dscam[TM2] are preferentially involved in dendritic elaboration and axonal 
arborization, respectively. This differential involvement of distinct Dscams is likely a 
result of differential protein targeting, because they are specified by similar cytoplasmic 
juxtamembrane portions of the Dscam exon 17-encoding TMs. However, after strong 
binary induction, transgenic Dscam[TM2] can exist abundantly in both dendrites and 
axons, whereas Dscam[TM1] remains primarily restricted to dendrites, although 
Dscam[TM1] exhibits more broad function than Dscam[TM2]. Knocking down both 
further impeded MB axons (Figure 4-2I), whereas eliminating exon 17.1-containing 
Dscam was equally potent as silencing all Dscam transcripts in the inhibition of PN 
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dendrites (Figure 4-3). These discrepancies suggest targeting-independent functional 
distinction between Dscam[TM1] and Dscam[TM2]. 
 Despite some recently raised concerns on the specificity of RNAi-mediated gene 
silencing (Ma et al., 2006), we are confident in this study for several reasons. First, it 
should be more straightforward to obviate potential off-target effects with the microRNA-
based RNAi constructs, because each of them only yields two 22-nucleotide-long double-
stranded RNAs. Second, we generated an independent miRNA-based RNAi construct 
against a common Dscam exon in addition to the ones targeting exon 17.1 versus exon 
17.2 and have obtained the expected results after analogous induction of RNAi against 
these discrete Dscam sequences. Third, the specificity and effectiveness of our RNAi was 
also confirmed by direct visualization of specific Dscam proteins in vivo. Fourth, all of 
our RNAi-induced phenotypes were comparable both qualitatively and quantitatively to 
previously known Dscam loss-of-function phenotypes. Fifth, we could also rescue the 
RNAi-mediated silencing of Dscam using appropriate Dscam transgenes. In addition, our 
demonstration that endogenous Dscam mediates dendritic versus axonal morphogenesis 
depending on the presence of TM1 or TM2 has been implicated by multiple independent 
lines of research. In particular, whereas transgenic Dscam with TM2 consistently rescues 
of Dscam mutant axons, Dscam[TM1] is much more potent than Dscam[TM2] in the 
rescue of Dscam mutant dendrite elaboration. 
 Alternative methods for knocking out subsets of isoforms mainly involve deletion 
of specific exon alternatives at the genomic level. In theory, by gene targeting (Gong and 
Golic, 2003), one can modify a genomic Dscam to carry only exon 17.1 or exon 17.2 in 
Drosophila. But such genomic manipulation is potentially problematic. Assuming simple 
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gene targeting does not alter the levels of Dscam expression, elimination of subsets of 
isoforms could inevitably lead to expression of other isoforms in much broader patterns 
and/or at higher levels than the normal unperturbed conditions. This may attenuate the 
defects resulting from the loss of specific isoforms and/or elicit additional phenotypes 
because of ectopic expression of the residual isoforms, further complicating 
interpretation. In contrast, knocking down various subsets of Dscam isoforms at the level 
of translation (e.g., by microRNA) should deplete the isoforms of interest without 
affecting the expression of others. This way, one can potentially map the endogenous 
patterns of expression for various specific subsets of Dscam isoforms and, more 
importantly, unequivocally determine the contributions made by given subsets of Dscam 
isoforms to various neural developments. In the case of Dscam[TM1] versus 
Dscam[TM2], we found that, although the relative abundance might differ at various 
developmental stages, they are apparently coexpressed in most cells. The coexpression 
with differential requirements implies that they are functionally distinct. Dscam[TM1] 
selectively concentrates in dendritic growth cones, whereas Dscam[TM2] is preferentially 
located to axonal growth cones. Nevertheless, we could not observe their differential 
targeting after depletion of one versus the other, because most neuropils are made up of 
both dendrites and axons. We also recently learned that retrograde transport plays an 
essential role in the dendritic enrichment of Dscam[TM1] (our unpublished results), 
potentially explaining why both Dscam[TM1] and Dscam[TM2] could be detected in the 
cores of larval MB peduncles where newly derived MB axons are selectively fasciculated 
(our unpublished observation). Finally, compared with the constitutive changes associated 
with gene targeting, GAL4/UAS-mediated targeted induction of RNAi permits more 
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varied control over when and/or where to knock down the isoforms of interest and should 
better illustrate the stage- as well as tissue-specific isoform-characteristic functions. 
 Together, our results indicate Dscams with distinct TMs are differentially 
involved in morphogenesis of dendrites versus axons, most likely because of differential 
protein targeting. What might be the advantages for having two exon alternatives to 
specify where a Dscam protein should be located? One possible advantage is the ability to 
independently control the Dscam repertoire at dendrite and axon within a single neuron. 
For instance, coupling different ectodomains with TM1 would permit selective 
enrichment of Dscams with distinct homophilic binding specificities in the dendrites but 
not axons. Additionally, for a given ectodomain, varying the ratio of TM1/TM2 could 
simultaneously alter the amounts of dendritic and axonal Dscams. Given that dendrites 
and axons of the same neurons often acquire different morphological characteristic 
features, it would be interesting to determine whether the TM1/TM2-governed 
differential distribution of Dscam directly underlies some aspects of the differential 
morphogenesis of dendrites versus axons. 
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Figure 4-1. Silencing of endogenous Dscam expression by various transgenic 
miRNAs.  
Composite confocal images of wandering larvae CNS showing endogenous Dscam 
expression (magenta; as revealed by immunostaining with an anti-Dscam exon 18 peptide 
mAb), in wild-type (WT) and after asense-GAL4/GAL4-C155-dependent induction of 
various anti-Dscam miRNAs (B–E). (A) Wild-type control. Note that UAS-18 miRNA 
alone (B) or only UAS-17.1 miRNA plus UAS-17.2 miRNA (C) could effectively 
eliminate the entire Dscam expression. In addition, regardless of the levels of Dscam, 
major neural structures, as revealed by coinduction of UAS-mCD8::GFP (green), 
remained comparable (insets). Scale bar: (here and in all figures) 20 µm. 
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Figure 4-2.  Dscam[TM2], but not Dscam[TM1], plays an essential role in MB 
axonal morphogenesis 
(A-E) Adult MB lobes visualized by 1D4 mAb. Compared with the wild type (A), induction of 
certain anti-Dscam miRNAs (see I) disrupted the formation of MB lobes to various extents (B-E). 
(F-H) Derivation of two chimeric Dscam TMs (F) and their effects on Dscam::GFP (green) 
protein targeting.  After binary induction with GAL4-201Y, Dscam[17.1/17.2]::GFP, like 
Dscam[TM2]::GFP, is uniformly distributed in the larval MBs (G).  In contrast, 
Dscam[17.2/17.1]::GFP, like Dscam[TM1]::GFP, is enriched in dendrites (H). Additionally, both 
Dscam[17.1/17.2]::GFP and Dscam[TM2]::GFP are preferentially targeted to axons after 
suppression of the induction by RNAi (data not shown) (similar to Figure 4-S1F and H). 
(I) Quantitative analysis of MB lobe phenotypes, based on the above classification (A-E), after 
GAL4-OK107-dependent induction of various anti-Dscam miRNAs and in the absence or 
presence of distinct transgenic Dscam::GFP.
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Figure 4-3. Dscam[TM1] and Dscam[TM2] primarily govern dendritic and axonal 
morphogenesis, respectively 
MARCM-labeled adult vPN Nb clones. Compared with the wild-type clone (A, green), 
induction of 17.1 miRNA, 17.2 miRNA, and 18 miRNA in vPN Nb clones (B–D, green) 
specifically disrupted dendritic elaboration (F, arrow), axonal arborization (K, arrow), 
and both (H, L; arrows), respectively. Adult fly brains were counterstained with nc82 
mAb (magenta). The cropped images selectively show dendritic elaboration (E–H) or 
axonal arborization (I–L) of the clones.
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Figure 4-4. Rescue of Dscam mutant PN morphogenesis by transgenic Dscam with 
TM1 versus TM2.  
(A-H) Adult single-cell clones of DL-1 PNs (green) of which the dendrite elaboration in the DL-1 
glomeruli (as revealed by nc82 immunostaining; magenta) and axon arborization in the MB 
calyces and the LHs are, respectively, shown in (A-D) and (E-H). (A) and (E), Wild-type clones. 
(B) and (F), Dscam mutant clones. (C) and (G), Rescueof mutant clones with pDscam-
Dscam[3.36.25.1-genomic 18-24]. (D) and (H), Rescue with pDscam-Dscam[3.36.25.2-genomic 
18-24]. Note partial coverage of DL-1 glomeruli by the green PN dendrites in (B) and (D) and the 
absence of bouton-like structures (arrowheads) in (F) and (G).  
(I-J) Quantitative analysis of the coverage of DL-1 glomeruli by single-cell PN clones (I) and the 
numbers of PN-derived bouton-like structures in the MB calyces (J). n=25 in every condition.  
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Figure 4-S1. Silencing of various UAS-transgenes by specific UAS-miRNAs  
Composite confocal images of wandering larval (WL) MBs showing suppression of the 
GAL4-201Y-dependent induction of UAS-Dscam3.36.25.1::GFP and UAS-
Dscam3.36.25.2::GFP by UAS-17.1 miRNA (C) and UAS-17.2 miRNA (F), respectively. 
In addition, UAS-18 miRNA antagonized the induction of both UAS-
Dscam3.36.25.1::GFP (G) and UAS-Dscam3.36.25.2::GFP (H), but not UAS-
mCD8::GFP (data not shown). Note that weak induction is necessary for demonstrating 
the preferential axon targeting of DscamTM2. For instance, the MB axon peduncle and 
lobes (e.g. arrowheads in F) are better labeled than the calyx when Dscam3.36.25.2::GFP 
was weakly expressed (F, H). 
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Figure 4-S2. Requirement of DscamTM2 for EB axonal morphogenesis  
Nb clones of adult EB neurons labeled with a flip-out reporter gene (A-C) or MARCM 
(D). Clones were generated in the absence of transgenic miRNA (A) or in the presence of 
UAS-17.1 miRNA (B) or UAS-17.2 miRNA (C). Note malformation of the EB ring 
following induction of UAS-17.2 miRNA (C). Similar phenotypes are observed in Dscam 
mutant clones (D). 
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Endodomain diversity in the Drosophila Dscam and its roles in  
neuronal morphogenesis  
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ABSTRACT 
 Drosophila Dscam can be variably spliced to encode 152,064 different single-
pass transmembrane proteins.  This involves derivation of 19,008 distinct ectodomains, 
two alternative transmembrane segments, and four endodomain variants.  Intriguingly, 
the wiring of adult fly neural circuitry primarily involves Dscam isoforms that lack both 
exon 19 and exon 23 in their coding of the endodomain.  Use of exon 19 is largely 
restricted to embryogenesis, and exon 23 is seldom included through development.  
Consistent with these patterns of exon usage, silencing of transcripts lacking exon 19 or 
23 effectively elicits loss-of-Dscam phenotypes in post-embryonic neuronal 
morphogenesis, while repressing exon 19-containing Dscam transcripts affects 
embryonic neuronal wiring.  Further, as compared to exon 19-containing Dscam, 
transgenic Dscam without exon 19 is more efficiently targeted to neurites and more 
potently suppresses axon bifurcation in Dscam mutant neurons.  In sum, Dscam with or 
without exon 19 in its endodomain potentially governs differential stage-specific 
neuronal morphogenesis. 
 
INTRODUCTION 
 The assembly of functional neural circuits from numerous neurons requires a 
series of cellular recognition events to specify correct axonal and dendritic patterns 
throughout development.  Neurite projection following the birth of neurons brings axons 
and dendrites into proximity where they often branch to make synaptic contacts with 
multiple targets.  One major challenge in this process is to distinguish self-branches from 
those of their neighboring neurons to prevent redundant connections.  In Drosophila, 
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Dscam (Down syndrome cell adhesion molecule) is primarily involved in the above 
process during neuronal morphogenesis including axonal guidance, axonal targeting and 
proper arborization of axons and dendrites (Chen et al., 2006; Wang et al., 2002; Zhu et 
al., 2006). 
 
Drosophila Dscam can encode 152,064 distinct immunoglobulin/fibronectin-type-
III cell adhesion molecules (Schmucker et al., 2000; Wang et al., 2004).  This derives 
from the presence of 19,008 variations, two alternatives, and four possibilities in its 
extracellular, transmembrane, and cytoplasmic domains, respectively.  The huge diversity 
in the ectodomain, known to bind with high affinity only to the ectodomain of the same 
kind, potentially underlies self-recognition for individual neurons (Wojtowicz et al., 
2004; Wojtowicz et al., 2007).  Repulsion as a consequence of the homophilic Dscam-
Dscam interactions may mediate self-avoidance among the neurites derived from the 
same cell while permitting fasciculation of neurites of different origins, to ensure proper 
patterning of multiple growth cones migrating simultaneously (Hughes et al., 2007; 
Matthews et al., 2007; Soba et al., 2007; Wojtowicz et al., 2004).  Further, elaboration of 
dendrites versus axons in the same neuron may involve different subsets of Dscam 
ectodomains, since a Dscam ectodomain can be selectively targeted to dendrites or axons 
depending on the nature of its transmembrane/juxtamembrane domain (Shi et al., 2007).  
 
Compared to well studied Dscam variants in the ectodomain and transmembrane/ 
juxtamembrane domain, little is known about the role of Dscam endodomain variants in 
neuronal morphogenesis.  A previous report has suggested that four possible Dscam 
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endodomains, ranging from exon 18 continuously extending to exon 24 or skipping exon 
19 and/or exon 23, are generated from independent alternative splicing of exon 19 and 
exon 23 (Wang et al., 2004).  The full-length Dscam endodomain, located on the 
carboxyl side of the exon 17-encoded transmembrane/juxtamembrane segment, consists 
of 367 amino acids.  It carries several putative SH3 binding sites, two 33 amino acid 
repeats that contain two  consensus SH2 binding motifs, a proline-rich motif, an 
immunoreceptor tyrosine-based activation like motif (ITAM-like) , an immunoreceptor 
tyrosine-based inhibition motif (ITIM), and a putative postsynaptic density, disc large 
and ZO-I protein (PDZ)-binding motif (Schmucker et al., 2000).  However, skipping 
exon 19 produces a Dscam protein without a proline-rich motif (PPVP) and an ITAM-
like (YxxLx(12)YxxA) sequence (Figure 5-1A).    By contrast, the exon 23 encodes 22 and 
one third amino acids, so skipping exon 23 makes a reading frame shift in the last exon 
24 that results in the loss of the ITIM (TAYDTM) and an PDZ-binding motif (TMAV) 
(Figure 1A).  Due to use of a different splicing donor site, four additional amino acids 
(TVIS) are added at the junction where exon 18 connects with exon 20 (Figure 5-1A).  
These differences in the primary sequence may confer different signaling and/or protein 
targeting properties on the Dscam endodomain variants, but their function in neural 
development still remains to be investigated.   
 
Here, we knocked down Dscam isoforms with specific endodomains to determine 
whether distinct Dscam endodomains are utilized to govern different Dscam-dependent 
neuronal morphogenetic processes.  A microRNA (miRNA)-based inducible RNA 
interference (RNAi) approach silences specific transcripts based on discrete 22-
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nucleotide sequences (Chen et al., 2007; Shi et al., 2007).  The miRNA-based silencing 
approach knocks down isoform expression after splicing, rather than in the transcriptional 
level through genomic manipulation. Thus, this technique should minimally affect the 
normal usage of isoforms that permits determination of isoform expression patterns and a 
direct demonstration of the involvement of distinct Dscam isoforms in different places 
and at different times.  Using this miRNA-based silencing technique, we were able to 
specifically silence Dscam transcripts carrying exon 19 or exon 23 via targeting the exon 
19- or exon 23-characteristic sequences, and to selectively deplete Dscam transcripts 
lacking exon 19 or exon 23 through RNAi against the unique sequences around the 
junction between exon 18 and exon 20 or between exon 22 and exon 24.  Selective 
elimination of Dscam isoforms either containing or lacking exons 19 and 23 followed by 
analysis of residual Dscam, as well as characterization of neuronal morphogenesis, 
revealed differential involvement of distinct Dscam endodomains in specific neuronal 
morphogenetic processes.  Notably, the wiring of adult fly neural circuitry primarily 
involves Dscam isoforms lacking both exon 19 and exon 23.  However, Dscam with exon 
19 plays a more dominant role than Dscam without exon 19 in supporting wiring of 
embryonic neural circuitry.  In addition, Dscam with exon 23 and Dscam without exon 23 
are expressed in different compartments of the developing nervous system.  Through 
characterization of transgenic Dscams with different endodomains, we further found that 
transgenic Dscam without exon 19 is more efficiently targeted to neurites and more 
potently suppresses axon bifurcation in Dscam mutant neurons than does exon 19-
containing Dscam.  Taken together, the huge repertoire of Drosophila Dscam 
ectodomains can govern diverse neural developmental processes not only through 
87 
 
alternative exon 17s to be targeted to dendrites versus axons, but also potentially via the 
use of four different endodomains to support distinct stage-specific or context-dependent 
neural development. 
 
 
MATERIALS AND METHODS 
Transgenic Constructs 
Standard molecular biological techniques were used to generate UAS-19 miRNA, UAS-23 
miRNA,  UAS-18/20 miRNA and UAS-22/24 miRNA, which encode microRNAs carrying 
unique Dscam sequences derived from exon 19, exon 23,  the junction between exon 18 
and exon20, and the junction between exon 22 and exon 24, respectively.  The complete 
nucleotide sequences of the microRNA constructs are indicated in Figure 1A and listed in 
the appendix.  UAS-18miRNA and four UAS-Dscam endodomain variants with the same 
ectodomain composition (UAS-Dscam[3.36.25.2]::GFPs) were described previously (Shi 
et al., 2007; Wang et al., 2004). 
 
Flies 
Transgenic flies carrying various UAS-miRNAs were obtained by P element-mediated 
germ line transformation with technical support from Genetic Services. 
 
Acute Induction of UAS-transgenes by TARGET system 
Larvae carrying two copies of tubulin promoter (tubP)-GAL80ts (McGuire et al., 2003) 
were cultured at the permissive temperature of 18°C throughout embryogenesis in order 
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to repress GAL4-mediated transcription.  Wandering larvae were shifted to 38°C for 30 
min, followed by incubation at the non-permissive temperature of 29°C for various 
periods.  
 
Isolation and analysis of Dscam exon 15-24 cDNAs 
Dscam exon 15-24 cDNAs were amplified by RT-PCR with the primers 
CAGGTCTATGCCACAGGATTCA and GACTCTAGATTACACTGCCATAGTATCG 
and subcloned into pBluescript with HindIII and XbaI as the cloning sites.  Multiple 
independent subclones were then individually analyzed for presence or absence of exon 
19 and/or exon 23 in their inserts.  Analysis was largely based on presence or absence of 
various exon-specific restriction enzyme sites and isoform-characteristic lengths of 
specific PCR products. 
 
RNAi induction and phenotypic analysis 
Targeted induction of UAS-miRNA involved use of various tissue-specific GAL4 drivers; 
and their phenotypic analysis mainly involved co-expression of various UAS-reporter 
genes.  The complete nucleotide sequences of the microRNA constructs are in the 
appendix. Rescue experiments by four different UAS-Dscam endodomain variants were 
analyzed in MARCM-labeled clones of α/β mushroom body neurons (MBs), which were 
induced one day before eclosion by heat shock for 30 min at 37ºC.  Whole fly brains 
were prepared for immunostaining as described previously (Lee et al., 1999).  Dscam 18 
monoclonal antibody (mAb) (Shi et al., 2007) and Dscam 19 rabbit polyclonal antibody 
(pAb), used to detect all versus exon 19-containing endogenous Dscam proteins, were a 
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mouse monoclonal antibody and a rabbit polyclonal antibody raised against epitopes in 
Dscam exon 18 (ATLDKRRPDLRDELG) and exon 19 (HSTWDPRRNPNLY), 
respectively.  The anti-Dscam 18 mAb, anti-Dscam 19 pAb1D4 mAb, anti-GFP and anti-
mCD8 mAb were used at 1:20, 1:1000, 1:500, and 1:100, respectively.  Fluorescence 
signals were captured with Zeiss confocal microscopy and processed using Adobe 
Photoshop to subtract background or adjust the signals by altering the linearity of the 
signals. 
 
RESULTS 
microRNA-based RNA interference permits differential silencing of Dscam 
transcripts encoding distinct endodomains 
 Based on analysis of RT-PCR products, there are four possible Dscam 
endodomain variants spanning the Dscam exon-16-to-polyA segment (Wang et al., 
2004).  The variations in the Dscam endodomain derive from presence or absence of 
exon 19 or exon 23 (Figure 5-1A).  To determine if Dscam uses different endodomains in 
support of different neural developmental processes, we selectively knocked down 
Dscam transcripts containing or lacking exons 19 and/or exon 23 using a miRNA-based 
RNAi technology that permits silencing of specific transcripts based on the presence of 
unique sequences that are only 22 nucleotide-long (Chen et al., 2007; Shi et al., 2007). 
 
By targeting exon 19- or exon 23-characteristic sequences or the unique 
sequences at the exon-exon junctions derived from skipping of exon 19 or exon 23 
(Figure 5-1A), we successfully silenced the expression of specific Dscam transgenes 
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based on presence or absence of exon 19 or exon 23.  Multiple independent transformants 
carrying UAS-19RNAi, UAS-18/20RNAi, UAS-23RNAi, or UAS-22/24RNAi were obtained 
and individually examined to identify the most effective RNAi transgenes for silencing 
their target-sequence-containing Dscam::GFPs in mature larval mushroom body (MB) 
neurons (Figure 5-1 and data not shown).  GAL4-201Y-dependent co-induction of distinct 
UAS-RNAis with a full-length Dscam (Dscam+19+23)::GFP or its derivative that skips 
both exon 19 and exon 23 (Dscam-19-23::GFP) further revealed that UAS-19RNAi 
(Figure 1C) and UAS-23RNAi (Figure 5-1E) effectively antagonized the expression of 
Dscam+19+23::GFP while minimally affecting the induction of Dscam-19-23::GFP 
which lacks the target sequences for these transgenic miRNAs (Figure 5-1G and I).   
Opposite results were obtained following co-induction of the Dscam::GFPs with UAS-
18/20RNAi or UAS-22/24RNAi (Figure 5-1B, D, F and H).  These observations justified 
the use of UAS-19RNAi, UAS-18/20RNAi, UAS-23RNAi, and UAS-22/24RNAi for 
selectively silencing exon 19-containing (Dscam+19), exon 19-lacking (Dscam-19), exon 
23-containing (Dscam+23) and exon 23-lacking (Dscam-23) Dscam transcripts, 
respectively. 
 
Differential expression of Dscams with different endodomains 
 We have made a UAS-18RNAi transgene targeting the exon 18 shared by all 
Dscam transcripts, and previously demonstrated that ubiquitous induction of UAS-
18RNAi abolished endogenous Dscam expression in the developing nervous system (Shi 
et al., 2007).  To determine the effectiveness of the above miRNA transgenes in silencing 
the endogenous expression of Dscam, we examined how induction of individual or 
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multiple Dscam miRNAs affected the endogenous patterns of Dscam expression at 
different developmental stages. 
 
In control embryos, immunostaining with an anti-Dscam exon 18 monoclonal 
antibody (Ab18) revealed concentration of endogenous Dscam on the ladder-like axonal 
tracks of the ventral ganglion (Figure 5-2A).  Such a stereotyped pattern of Dscam 
distribution was completely eliminated by tubulin promoter (tubP)-GAL4-dependent 
ubiquitous induction of UAS-18RNAi, UAS-19RNAi plus UAS-18/20RNAi or UAS-
23RNAi plus UAS-22/24RNAi (Figure 5-2D, E and H).  It was noted that pan-neuronal 
induction of UAS-18RNAi by GAL4-C155 plus Asense-GAL4 could not deplete the 
ladder-like axonal expression of endogenous Dscam, possibly due to late or insufficient 
induction of RNAi (data not shown).  In contrast, residual Dscam persisted following 
tubP-GAL4-dependent induction of only one of the paired UAS-RNAis, even with 
multiple copies (data not shown).  Comparing the induction of UAS-19RNAi versus UAS-
18/20RNAi, the ladder-like patterns of immunostaining, though weakened, looked 
morphologically indistinguishable from those seen in control embryos (Figure 5-2B and 
C).  Intriguingly, when endogenous Dscam was silenced by UAS-23RNAi or UAS-
22/24RNAi, we found that the whole Dscam distribution can be subdivided into two non-
overlapping compartments that exclusively contain Dscam+23 and Dscam-23, 
respectively (Figure 5-2F-G).  Residual Dscam was completely restricted to the midline 
of the ventral ganglion, following induction of UAS-22/24RNAi (Figure 5-2F).  Closer 
inspection revealed the midline localization of Dscam in control embryos as well (Figure 
5-2A, 5-3A and D); and the midline expression of Dscam was only abolished by 
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induction of UAS-23RNAi that otherwise did not affect the pattern or intensity of the 
endogenous Dscam expression (Figure 5-2F versus Figure 5-2B, C and G).  These 
phenomena indicate that, in embryos, Dscam+19 or Dscam-19 is coexpressed in the same 
neurons while Dscam+23 or Dscam-23 is differentially expressed. 
 
Similar analysis of Dscam expression in the late larval central nervous system 
(CNS) revealed that the endogenous Dscam mostly lacks exon 19 and exon 23.  Pan-
neuronal induction of either UAS-19RNAi or UAS-23RNAi to deplete Dscam+19 or 
Dscam+23 minimally affected the expression pattern or level of endogenous Dscam 
(Figure 5-2K and O).  Consistent with these observations, depleting the Dscams-19 or 
Dscam-23 drastically reduced the Dscam expression in the late larval CNS (Figure 5-2J 
and N).  Intriguingly, distinct patterns of residual Dscam were detected.  Upon induction 
of UAS-18/20RNAi to eliminate Dscam-19, the residual Dscam, though barely detectable, 
existed in a similar pattern to that of control animals (Figure 5-2I and J).  In contrast, 
induction of UAS-22/24RNAi to silence Dscam-23 transcripts selectively depleted 
endogenous Dscam from those neuropil structures where Dscam is normally enriched 
(Figure 5-2N).  These results suggest that larval development of the Drosophila CNS is 
mainly supported by Dscam-19-23 isoforms.  In addition, Dscam+23 or Dscam-23 exists 
in distinct patterns, though not as exclusive as in embryos, and potentially governs 
different morphogenetic processes through development of the Drosophila CNS. 
 
To validate some of the above conclusions, we sought to locate Dscam+19 
directly by immunostaining with exon 19-targeted antibody (Ab19), a polyclonal 
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antibody raised against a peptide sequence characteristic of Dscam exon 19.  The Ab19 
selectively bound to ectopic Dscam+19::GFP (data not shown).  Further, a similar ladder-
like pattern of immunocytochemical signals, which was eliminated in Dscam-null 
embryos, was detected following immuonstaining of wild-type embryos with the Ab18 or 
Ab19 (Figure 5-3A-B and 5-3D-E).  These results demonstrate that the Ab19 specifically 
binds with Dscam+19.  When the Ab18 and the Ab19 were used to label all the Dscam 
isoforms or Dscam+19 isoforms in the late larval CNS, we detected abundant Dscam 
expression only with the Ab18 (Figure 5-3C and F).  This substantiates the notion that 
Dscam+19 is largely absent during post-embryonic development of the fly CNS.  These 
results are also consistent with the use of transgenic miRNAs to silence alternative 
transcripts in identifying the expression patterns of distinct isoforms in vivo. 
 
Analysis of Dscam transcripts by RT-PCR revealed that the dynamic usage of 
exon 19 and exon 23 is evident even at the mRNA level.  The relative abundance of 
Dscam transcripts encoding distinct endodomains varied at different developmental 
stages.  The expression of Dscam+19 transcripts in the CNS drastically decreased from 
embryos (65.8%) to larvae (15.8%), became negligible by puparium formation (0%), and 
returned after eclosion (31.6%).  In contrast, Dscam+23 transcripts rarely existed in 
embryos (2.6%), significantly increased in larvae (7.9%) and pupae (10.4%), and further 
doubled in the relative abundance in adult brains (21.1%).  The differential expression of 
Dscam mRNA splicing variants at different developmental stages can account for the 
differences we detected in the abundance of distinct endodomains at the protein level.  
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These results suggest that the dynamic expression of distinct Dscam endodomains is 
likely controlled through regulation of alternative splicing. 
 
Taken together, these observations not only indicate that distinct Dscam 
endodomain isoforms do exist in vivo, but also demonstrate that the miRNA-based RNAi 
reagents work effectively to antagonize expression of each isoform while minimally 
affecting the alternative splice form.  Differential induction of these isoforms should 
allow us to determine where Dscams with specific endodomains are distributed in vivo.  
Notably, examining the expression of Dscam+23 uncovers two distinct populations of 
Dscam-positive structures that may potentially utilize different Dscam endodomains for 
supporting different morphogenetic processes. 
 
Wiring of the adult fly neural circuitry primarily involves Dscam-19-23 transcripts 
 Based on the above analysis on endogenous expression patterns of Dscam 
endodomain variants, Dscam-19-23 may support diverse neuronal morphogenesis during 
larval and pupal stages.  This raises the possibility that wiring of the fly neural circuitry 
primarily involves Dscam-19-23.  To test this hypothesis, we examined how silencing of 
Dscam transcripts encoding specific endodomains by targeted RNAi affects 
morphogenesis of two distinct types of larval-born neurons where Dscam loss-of-function 
phenotypes are known.  We found in both MB neurons and the ellipsoid body (EB) 
neurons, that induction of UAS-18/20RNAi or UAS-22/24RNAi, but not UAS-19RNAi or 
UAS-23RNAi, effectively elicited the phenotypes characteristic of loss of Dscam function 
(Figure 5-4A-C and data not shown). 
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For example, Dscam governs axon bifurcation by preventing sister growth cones 
from migrating along the same path in the MB neurons (Wang et al., 2002).  It ensures 
formation of paired MB lobes that normally lie perpendicular to each other and are 
comparable in bundle thickness.  By contrast, when Dscam is absent, MB axons undergo 
excessive bifurcation, and their sister branches are no longer consistently segregated.  
These abnormalities underlie overgrowth of one MB lobe at the expense of its paired one.  
To determine the roles of Dscam+19, Dscam-19, Dscam+23 or Dscam-23 in MB 
morphogenesis, we examined which of the above anti-Dscam miRNA transgenes could 
be induced to elicit these loss-of-Dscam MB phenotypes.  We first demonstrated that 
GAL4-OK107-driven induction of UAS-18RNAi caused defects in MB lobe morphology 
(Figure 5-4A and B).  Instead of having two comparable axon lobes, 88% of the MBs 
acquired one huge and one skinny lobe (Figure 5-4C).  This anomaly replicated Dscam 
mutant MB phenotypes (Wang et al., 2002).  Since silencing Dscam with UAS-18RNAi 
eliminates all Dscam isoforms, this result has not only confirmed the efficiency of 
knocking down endogenous Dscam by transgenic miRNA, but also given us an 
opportunity for learning what Dscam “null” phenotypes to expect in the MBs following 
the suppression of specific Dscam endodomain isoforms.  Notably, induction of UAS-
19RNAi and UAS-18/20RNAi or with UAS-23RNAi versus UAS-22/24RNAi yielded 
different effects (Figure 5-4C).  While induction of UAS-19RNAi or UAS-23RNAi to 
deplete Dscam+19 or Dscam+23 failed to affect MB morphogenesis, 68% and 77% of 
the MBs acquired asymmetric axon lobes following silencing of Dscam-19 or Dscam-23 
using UAS-18/20RNAi or UAS-22/24RNAi (Figure 5-4C).  This suggests that Dscam-19 
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and Dscam-23 are indispensable for gross morphogenesis of the MBs.  However, the 
penetrance of UAS-18/20RNAi-induced MB phenotypes increased from 68% to 89% 
following co-induction with UAS-19RNAi, supporting a lesser role for Dscam+19 in 
mediating the neuronal morphogenetic processes mainly governed by Dscam-19-23.  By 
contrast, co-induction of UAS-22/24RNAi and UAS-23RNAi minimally enhanced the MB 
phenotype, suggesting again that Dscam-23 is dispensable in the neuronal 
morphogenesis.  Taken together, these results indicate that the Dscam-dependent MB 
lobe formation primarily involves Dscams-19-23, which is consistent with Dscam-19-23 
being predominantly expressed through post-embryonic CNS development. 
 
Dscam-19 is selectively involved in embryonic neuronal morphogenesis 
 In contrast with Dscam-23 whose usage remains low through different 
developmental stages, both Dscam+19 and Dscam-19 are abundantly expressed in 
embryonic CNSs.  To reveal the role of Dscam exon 19 variants in neural development, 
we examined if eliminating Dscam+19 or Dscam-19 affects embryonic neuronal 
morphogenesis.  We characterized neurite tracks in the embryonic ventral ganglion that 
typically consists of bilaterally symmetric longitudinal fascicles connected across the 
midline via repeated pairs of commissure bundles.  Although aberrant neurite tracks in 
Dscam mutant embryos have been reported (Schmucker et al., 2000), ubiquitous 
induction of UAS-18RNAi failed to disrupt the ladder-like neuronal tracks in otherwise 
wild-type embryos (Figure 5-4F).  Recent studies showed that Dscam loss-of-function 
phenotypes in embryos can be significantly enhanced in tyrosine kinase abelson (abl) 
mutant backgrounds (Andrews et al., 2008).  Prompted by this unpublished observation, 
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we examined how silencing Dscam by RNAi might affect neural track development in abl 
mutant embryos (Figure 5-4D and E).  Similar to the Dscam-depleted embryos caused by 
tubP-GAL4-dependent induction of UAS-18RNAi, the ladder-like neurite tracks were 
grossly normal in abl2/abl 4 mutant embryos (Figure 5-4F).  In contrast, the ubiquitous 
induction of UAS-18RNAi in abl2/abl 4 mutant embryos effectively blocked midline 
crossing of neurites and caused commissureless phenotypes in 19% of the ventral 
ganglion segments (Figure 5-4E and F).  This sets a stage for determining the roles of 
various Dscams in embryonic neuronal morphogenesis by RNAi using distinct Dscam-
targeted miRNAs. 
 
To tell the respective contributions made by Dscam+19 and Dscam-19, we 
silenced Dscam transcripts containing or lacking exon 19 in the abl2/abl 4 mutant 
background.  Following analogous induction with tubP-GAL4, UAS-19RNAi and UAS-
18/20RNAi elicited commissureless phenotypes in 9% and 1% of the ventral ganglion 
segments, respectively (Figure 5-4F).  This demonstrates that Dscam+19 plays an 
essential and more dominant role than Dscam-19 in the development of the Drosophila 
embryonic CNS.  Again consistent with the differential usage of exon 19 during versus 
after embryogenesis, endogenous Dscam+19 is preferred in supporting embryonic 
neuronal morphogenesis while governing post-embryonic neuronal development utilizing 
the Dscam-19. 
 
Differential rescue of axon branching phenotypes by transgenic Dscam +19 or 
Dscam-19 
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 To start understanding why Dscam with specific endodomains is utilized in 
specific contexts, we examined whether ectopic expression of Dscams with different 
endodomains may act differentially in vivo.  Although MB morphogenesis primarily 
involves Dscam-19-23, past studies have shown that the Dscam+19+23 transgene, no 
matter which ectodomain it carries and whether it is fused with GFP at the carboxyl 
terminus or not, can effectively prevent sister branches from extending into the same 
axon bundle in single-cell clones of Dscam mutant neurons (Wang et al., 2004; Zhan et 
al., 2004; Soba et al., 2007).  We wondered if Dscam transgenes that encode Dscams with 
distinct endodomains may vary in their ability to restore the normal pattern of axon 
bifurcation and segregation in Dscam mutant MB neurons. 
 
UAS-Dscam::GFPs that encode the same ectodomain connected to one of the four 
possible endodomains through the exon 17.2-defined transmembrane domain were 
identified by their comparable induction expression level with the same GAL4 driver 
(Figure 5-5A).  We examined how expression of each of the representative Dscam 
transgenes exclusively in Dscam mutant single-cell MARCM clones affects their axon 
bifurcation and segregation at the MB peduncle terminus.  We focused on the analysis of 
MB α/β neurons, whose axons extend through the peduncle, undergo bifurcation at the 
peduncle end, and then innervate the MB α and β lobes with only one primary branch 
from each neuron (Figure 5-5C).  Single-cell MARCM clones of MB α/β neurons were 
derived following mitotic recombination induced during mid-pupal development.  Loss 
of the GAL4 repressor, GAL80, in the clones led to derepression of GAL4-OK107, which 
in turn drove expression of UAS-mCD8::GFP for marking the clones uniquely.  In the 
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rescue experiments, the derepressed GAL4-OK107 also activated one of the UAS-
Dscam::GFPs specifically in the clones.  Given that these Dscam transgenes vary only in 
the presence or absence of exon 19 or 23, any differences in the phenotypes of Dscam 
mutant α/β neurons that have expressed different UAS-Dscam::GFPs can be fully 
ascribed to the differences in Dscam protein distribution and/or function due to the 
involvement of different endodomains. 
 
As reported previously, single-cell MARCM clones of Dscam mutant MB α/β 
neurons could not effectively segregate their sister branches to prevent multiple neurites 
of the same cellular origin from extending into the same MB lobe (Wang et al., 2002).  
Although Dscam mutant neurons might acquire supernumerary branches, this segregation 
problem was evident even in the mutant axons that only bifurcated once at the peduncle 
end.  Failure in the divergent segregation of sister branches appears to be the primary 
defect (Figure 5-5D-F).  97% of Dscam mutant single-cell MARCM clones of MB α/β 
neurons sent two or more neurites into one MB axon, exhibiting the multi-branches/lobe 
phenotype (Figure 5-5B-F).  By this measure, single-isoform Dscam-19 transgenes were 
similar to single-isoform Dscam+19 transgenes in restoring the Dscam mutant multi-
branches/lobe phenotype to the wild-type phenotype (Figure 5-5B).  Failure in divergent 
segregation (multi-branches/lobe) was observed in 22%, 16%, 25%, and 22% of Dscam 
mutant MB α/β neurons (as opposed to 97% in the absence of any rescuing construct) that 
were rescued by the transgenes of Dscam+19+23, Dscam-19+23, Dscam+19-23 and 
Dscam-19-23, respectively (Figure 5-5B).  In addition, among the rescued single-cell 
MARCM clones (without the multi-branches/lobe phenotype), we detected a single-
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branch/neuron phenotype in which the axon did not bifurcate at the peduncle end and 
stochastically projected into the α or β lobe.  Intriguingly, many more rescued single-cell 
MARCM clones exhibited the single-branch/neuron phenotype (no bifurcation despite 
presence of both α and β lobes), when the mutant clones were supplemented with Dscam-
19 transgenes (Figure 5-5G).  For the Dscam-19+23 and Dscam-19-23 transgenes, 11% 
and 13% of Dscam mutant single-cell clones extended their single axonal processes into 
the α and β lobes without branching at the normal bifurcation point around the peduncle 
terminus (Figure 5-5B).  In contrast, only 5% and 5% were obtained with the 
Dscam+19+23 and Dscam+19-23 transgenes, respectively, (Figure 5-5B).  In addition, 
overexpressing the Dscam-19+23 transgene in wild-type single-cell MARCM clones 
only resulted in 3% single-branch phenotype (Figure 5-5B).  Taken together, no matter 
whether exon 23 is present or not, Dscam-19 transgenes more potently modulate the axon 
bifurcation and segregation patterns than Dscam+19 transgenes.  These observations 
suggest some exon 19-dependent modification of protein distribution or function that is 
relevant to where or how Dscam may signal to govern MB axonal morphogenesis. 
 
Transgenic Dscam-19 is preferentially targeted to neurites while Dscam+19 can be 
significantly sequestered in neuronal cell bodies 
 To understand the logic behind the exon 19-dependent functional differences, we 
visualized the protein distribution of Dscam+19::GFP and Dscam-19::GFP  transgenes 
in vivo.  Previously, we have reported the differential protein distribution in the larval 
MBs when UAS- Dscam+19::GFP and UAS-Dscam-19::GFP transgenes were 
ectopically expressed in mature larval MB neurons using GAL4-201Y (Wang et al., 
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2004).  Notably, the Dscam+19::GFP and Dscam-19::GFP were found to be enriched in 
cell bodies and neurites of the larval MBs, respectively.  This raises the possibility that 
Dscam protein distribution may vary depending on the presence or absence of exon 19. 
 
However, GAL4-201Y drove expression of Dscam::GFPs in excessive amounts 
and in mature MB neurons, which is in great contrast with the endogenous Dscam being 
expressed at a much lower level and typically in newly derived post-mitotic neurons.  To 
ascertain the role of exon 19 in Dscam protein distribution, we examined whether 
Dscam+19::GFP and Dscam-19::GFP remain differentially localized upon weak 
induction in young MB neurons.  Transient binary induction of UAS-transgene is 
possible with the TARGET system, in which GAL4 activity is suppressed until 
inactivation of temperature-sensitive GAL80 at a restrictive temperature (McGuire et al., 
2003).  Derepression of GAL4-OK107 following a heat shock to inactivate GAL80ts 
allowed one to weakly express UAS-transgene in young MB neurons as judged by the 
central localization of neurites in the age-dependent concentrically organized axon 
bundles.  Similar transient induction of UAS-Dscam::GFPs again revealed that Dscam-
19::GFP, but not Dscam+19::GFP, was selectively enriched in the neurites (Figure 5-6A-
D).  While Dscam-19::GFP primarily labels the MB axon bundles (Figure 5-6B and 5-
6D), Dscam+19::GFP significantly accumulates in cell bodies despite a low-level 
induction in the MB neurons where endogenous Dscam is expressed (Figure 5-6A and 
C).  This result indicates that Dscam-19 is better targeted to the extending neurites, 
potentially explaining why transgenic Dscam-19 is more potent than the Dscam+19 in 
modulating post-embryonic neuronal morphogenesis. 
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DISCUSSION 
 Besides the huge diversity in the ectodomain and two choices in the 
transmembrane domain, endogenous Dscam can carry four distinct endodomains 
resulting from the alternative splicing of exon 19 and exon 23.  Dscams with different 
endodomains are differentially expressed through development of the Drosophila CNS.  
These conclusions are supported by multiple observations, including (1) the analysis of 
Dscam transcript compositions by RT-PCR, (2) the localization of specific Dscam 
endodomains by depleting the alternatives via miRNAs against exon 19, exon 23, or the 
unique exon-exon junctions derived from skipping of exon 19 or exon 23 (Figure 5-2), 
and (3) the direct visualization of Dscam+19 using Ab19 as opposed to labeling all the 
Dscam isoforms with Ab18 (Figure 5-3).  The differential expression of distinct Dscam 
endodomain variants suggests diverse Dscam function and implicates possible 
involvement of Dscams with different endodomains in governing differential neuronal 
development or function.  Interestingly, post-embryonic neuronal morphogenesis 
primarily utilizes Dscam-19-23 (Figure 5-4C).  In contrast, Dscam+19 plays a more 
dominant role in the wiring of embryonic neural tracks (Figure 5-4F).  Skipping exon 19 
promotes targeting of Dscams to the neurites in post-embryonic neurons, suggesting a 
mechanism for regulating Dscam protein targeting by the alternative splicing of exon 19 
(Figure 5-6).  In addition, exon 23 is dispensable to most Dscam-dependent neuronal 
morphogenetic processes but present in probably all the Dscam molecules in certain 
neural structures, suggesting an unidentified Dscam function in the developing 
Drosophila CNS (Figure 5-3C and F). 
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Four different Dscam endodomain variants exist from independent alternative 
splicing by skipping exon 19 or exon 23.  Possible approaches to study the role of these 
Dscam endodomain variants in neuronal morphogenesis include: (1) manipulating Dscam 
at the genomic level by gene-targeting (Gong and Golic, 2003), or (2) silencing different 
Dscam endodomain transcripts by RNAi (Chen et al., 2007; Shi et al., 2007).  Deleting 
genomic sequence to manipulate alternative exon choice might be problematic, since 
elimination of specific Dscam endodomain variants inevitably leads to expression of 
other isoforms in much broader patterns and/or at higher levels than the normal 
unperturbed conditions.  In contrast, knock-down of Dscam endodomain variants at the 
translational level by RNAi should deplete the isoforms of interest without affecting the 
expression of others.  Further, by targeting the junction spanning different exons (Figure 
1), the miRNA-based silencing approach allowed us to selectively deplete isoforms that 
lack any unique exon shared by the isoform subset.  It is also noted that this miRNA-
based knock-down could eliminate endogenous Dscam expression at the embryonic 
stage, while double-stranded RNA-based knock-down generally did not work at this stage 
(Figure 2E; Yu et al., unpublished observation).  
 
Using miRNA-based knock-down and immonostaining of isoform-specific 
antibodies, we found that Dscam+19 or Dscam-19 may redundantly govern neuronal 
morphogenesis but is preferentially utilized at different developmental stages (Figure 5-2 
and 5-3).  In contrast, most neuronal morphogenetic processes might exclusively use 
Dscam-23 (Figure 5-3C); and Dscam+23, though weakly expressed in the developing 
CNS, potentially supports some unknown Dscam function (Figure 5-2F and N).  With 
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respect to the alternative splicing of exon 19, Dscam+19 is primarily used during 
embryogenesis, but becomes rarely expressed in the post-embryonic nervous system 
(Figure 5-3D and F).  However, Dscam+19 and Dscam-19 exhibit similar spatial 
expression patterns despite the dynamic changes in the relative abundance (Figure 5-2B-
C and 5-2J-K).  Consistent with these expression profiles, endogenous Dscam-19 plays 
an essential role in post-embryonic neuronal morphogenesis, while Dscam+19 plays a 
supportive role in the same morphogenetic processes (Figure 5-3C).  The opposite 
situation applies in the embryonic ventral ganglion (Figure 5-3F).  In contrast, Dscam+23 
and Dscam-23 are enriched in different neural structures at the same developmental 
stages (Figure 5-2F-G and 5-2N-O).  It appears that the dominant Dscam expression 
domains exclusively consist of Dscam-23.  And, locating Dscam+23 has revealed 
previously uncharacterized Dscam expression regions (Figure 5-2F).  Consistent with 
this, depleting Dscam-23 transcripts only was sufficient to recapitulate the loss-of-Dscam 
phenotype (Figure 5-3C).  Elucidation of the function of Dscam+23 may depend on the 
identification and better characterization of the neural structures whose Dscams 
invariantly contain exon 23. 
 
Analysis of the differences in the primary sequences of distinct endodomains may 
confer insights about different signaling and/or protein-targeting properties of the Dscam 
endodomain variants.  For example, skipping exon 19 produces the Dscam without a 
proline-rich motif and an ITAM-like (Figure 5-1A).  An ITAM is defined by a motif 
containing two tyrosine residues within the consensus sequence of YxxI/Lx(6-12)YxxI/L 
(Fodor et al., 2006).  Instead of the conserved Ile/Leu adjacent to the second tyrosine 
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residue in most of ITAM containing proteins, Ala is used in that position in Dscam 
(Figure 5-1A).  Although rare, it is not unprecedented since a similar variation has been 
found in RhoH, a hematopoietic-specific GTPase-deficient member of Rho GTPase 
family (Gu et al., 2006).  Whether the ITAM-like domain in Dscam can mediate the 
canonical ITAM-involved signal transduction pathway to control cellular responses 
awaits investigation.  Nonetheless, transgenic Dscams are enriched in different 
subcellular compartments depending on the presence or absence of exon 19 (Figure 5-6).  
In the MBs, transgenic Dscam-19 is preferentially targeted to neurites while transgenic 
Dscam+19 can be significantly sequestered in neuronal cell bodies.  Similar patterns of 
differential protein distribution were detected in the projection neurons (PNs) following 
targeted induction of transgenic Dscams with different endodomains (Yu et al., 
unpublished observation).  This nicely correlates with the phenomena that transgenic 
Dscam-19 acted more potently than Dscam+19 in altering neurite projection patterns in 
both MB neurons and PNs (Yu et al., unpublished observation).  Whether the proline-rich 
motif and/or the ITAM-like sequence within the exon 19 make Dscam-19 variants easier 
to target to neurite projections also awaits further investigation.  But this primary 
sequence analysis sometimes is unable to provide insight into why Dscams with specific 
endodomains are utilized in specific contexts.  The difference between Dscam+23 and 
Dcam-23 is that the latter variant lacks exon 23, which results in the loss of the ITIM and 
PDZ-binding motif (Figure 5-1A).  However, transgenic Dscams behaved 
indiscriminately in the presence or absence of exon 23, yielding no insight into why 
Dscam-23 is pre-selected in most, if not all, known Dscam-dependent neuronal 
morphogenetic processes (Figure 5-5B).  In addition, it is paradoxical for Dscam+19, 
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which may not be as efficiently targeted to the extending neurites as is Dscam-19, to be 
predominantly used in supporting embryonic neuronal morphogenesis (Figure 3F).  
Nevertheless, the spatial distribution of endogenous Dscam in the embryonic ventral 
ganglion did not change following depletion of Dscam+19 or Dscam-19, suggesting that 
exon 19 may regulate Dscam protein targeting differentially in a stage-specific manner 
(Figure 5-2B-C and 5-2J-K). 
 
Transgenic Dscam-19 not only effectively prevents multiple self-branches from 
extending into the same MB lobe in Dscam mutant single-cell MARCM clones, but also 
blockes axon bifurcation, which results in a single-branch/neuron phenotype in a 
significant number of the rescued single-cell MARCM clones (Figure 5-5).  The single-
branch/neuron phenotype is apparently elicited by a cell-autonomous mechanism, and 
cannot be readily explained based on our current model about the roles of Dscam in 
controlling axon arborization (Figure 5-5B and 5-5G).  Two known mechanisms may 
suppress MB bifurcation at the peduncle end.  First, the competition among self-branches 
for the available separate fascicles probably underlies the phenomenon that neurons can 
reliably make the correct numbers of branches based on the numbers of fascicles that 
project off the branch point.  This may explain why MB α/β axons do not bifurcate when 
the α or β lobe is missing (Wang et al., 2002).  Second, promiscuous competition from 
non-self-branches is thought to occur and, as a consequence, stops most axons from 
extending beyond the bifurcation point when the endogenous Dscam gene loses its 
ectodomain diversity or a single-isoform Dscam transgene is ubiquitously expressed 
(Wang et al., 2004; Hattori et al., 2007).  Both pathological conditions are caused by 
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environmental factors through non-autonomous mechanisms.  By contrast, in the clone-
specific rescue experiments, the α and β lobes were both normal, and the Dscam 
transgene was only expressed in the neuron that exhibited the single-branch/neuron 
phenotype (Figure 5-5G).  These results clearly suggest a novel cell-autonomous 
mechanism for Dscam in governing neurite arborization.  Further, it is unlikely to be due 
to excessive Dscam expression, since the UAS transgenes can only be barely expressed in 
the newly-derived single-cell MARCM clones owing to the perdurance of GAL80 
inherited from the heterozygous ganglion mother cells.  In addition, overexpressing an 
UAS-Dscam-19+23 transgene in the wild-type MB α/β MARCM clones which should 
increase the overall Dscam amount did not result in obvious single-branch/neuron 
phenotype (Figure 5-5B).  Therefore, the suppression of axon bifurcation is likely to 
result from loss of Dscam ectodomain diversity in a single neuron, suggesting that the 
huge molecular diversity in the Dscam ectodomain is not only essential for self-
recognition among numerous migrating growth cones but also critical to the behavior of 
an isolated growth cone.  It is possible that the complexity of the expressed Dscam 
ectodomains in a given neuron at a given time may determine the strength of Dscam-
Dscam homophilic signaling between the nascent split growth cones and, thus, help 
govern how divergently the sister growth cones should migrate away without 
compromising each other. 
 
Taken together, we substantiate the presence of four possible Dscam 
endodomains and demonstrate that Dscams with specific endodomains are involved in 
supporting specific neural developmental processes.  The identification and 
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characterization of the diversity and function in the Dscam endodomain has laid a solid 
ground for further elucidating the roles of Dscam, a huge repertoire of cell adhesion 
molecules, in neural development as well as the innate immunity of insects (Watson et 
al., 2005).  It also provides new insights into how the diversity in the Dscam ectodomain 
may cell-autonomously govern neurite arborization, and suggests an exon 23-dependent 
unidentified Dscam function for supporting the development of Drosophila CNS. 
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Figure 5-1.  Amino acid sequences of four different Dscam endodomain variants and 
silencing of various UAS-transgenes by specific UAS-miRNAs 
(A) Amino acid sequences of four Dscam endodomain variants, full length (+19+23), 
missing exon 19 only (-19+23), lacking exon 23 only (+19-23), and omitting both exon 
19 and exon 23 (-19-23), are aligned within the cytoplasmic domain from exon 18 to 
exon 24.  Common sequence between exon20 and exon22 is not shown.  Four extra 
amino acids (TVIS) are in the Dscam variants which skip exon 19.  Amino acids shown 
in italicized resulting from a reading frame shift on exon 24 is observed when the Dscam 
variants skip exon 23.  Target sequences for different UAS- miRNAs (18i, 18/20i, 19i, 
22/24i and 23i) to eliminate different Dscam variants are indicated.  (B-I) Composite 
confocal images of wandering larval MBs showed suppression of the GAL4-201Y-
dependent induction of UAS-Dscam+19+23::GFP (B-E) and UAS-Dscam-19-23::GFP 
(F-I) by UAS-18/20 miRNA (B, F), UAS-19 miRNA (C, G), UAS-22/24 miRNA (D, H) and 
UAS-23 miRNA (E, I), respectively.  The scale bar in this and all other figures equals 50 
µm. 
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Figure 5-2.  Differential and dynamic endogenous expression of Dscam endodoamin 
variants revealed by transgenic miRNAs knock-down 
Composite confocal images of embryonic and wandering larval CNS showing 
endogenous Dscam expression (revealed by immunostaining with an anti-Dscam exon 18 
monoclonal Ab), following tubP-GAL4-dependent (A-H) or GAL4-OK107-dependent (I-
P) induction of various anti-Dscam miRNAs, including UAS-18 miRNA (E, M), UAS-
18/20 miRNA (B, J), UAS-19 miRNA (C, K), UAS-18/20 miRNA plus UAS-19 miRNA (D, 
L), UAS-22/24 miRNA (F, N), UAS-23 miRNA (G, O) or UAS-22/24 miRNA plus UAS-23 
miRNA (H, P).  Arrows point at the midline in F. 
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Figure 5-3.  Endogenous expression of Dscam exon 19 variants revealed by Dscam 
antibodies 
An anti-Dscam exon 18 monoclonal antibody (Ab18) recognizing all Dscam proteins (A-
C) and an anti-Dscam exon 19 polyclonal antibody (Ab19) recognizing Dscam+19 
proteins (D-F) were used to reveal the endogenous expression pattern of Dscam+19 
during development.  Both Ab18 and Ab19 are specific for detecting Dscam endogenous 
proteins as evidently by lack of immunostaining in Dscam null mutant embryos (B, E).  
Arrows point at the midline in A and D. 
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Figure 5-4.  The role of Dscam endodomain variants in embryonic CNS and larval 
MB axonal morphogenesis 
(A-C) Quantitative analysis of wandering larval MB lobe phenotype followed GAL4-
OK107-dependent induction of various UAS-Dscam miRNAs.  Skinny lobe phenotype 
(arrows) was observed when Dscam-19 and/or Dscam-23 were eliminated.  (D-F) 
Quantitative analysis of embryonic CNS commissureless phenotype (arrows) followed 
tubP-GAL4-dependent induction of various UAS-Dscam miRNAs.  No phenotype was 
observed when all Dscam proteins were knocked down alone or in abelson (abl) mutant 
embryos. However, the commissureless phenotype was observed when all Dscam or 
Dscam+19 proteins were eliminated in the abl mutant embryos. 
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Figure 5-5.  Rescue of multi-branch Dscam mutant MB α/β phenotype by transgenic 
Dscam with four different Dscam endodomain variants 
(A) Dscam endodomain variants with a similar expression level were chosen to rescue 
the multi-branch Dscam mutant MB α/β phenotype.  Heat shock-GAL4 was used to drive 
the expression of different Dscam endodomain variants by brief heat shock at 37ºC.  The 
expression level of heat shock animals were analyzed by the Western blot.  (B-G) 
Quantitative analysis of different MB α/β neuronal phenotypes was shown when different 
Dscam endodomain variants were introduced in Dscam mutant MARCM clones (B).  
Normally, only one primary branch from each neuron was observed in each adult MB α 
and β lobes (C).  However, multi-branch phenotype with two or three branches on one 
MB lobe was observed in Dscam mutant MARCM clones (D-F).  In addition, an unusual 
single-branch phenotype was also observed when Dscam endodomain variants were 
overexpressed in Dscam mutant MARCM clones (G).  Antibody 1D4 (magenta) was 
used to reveal adult MB α/β lobes.  Anti-mCD8 antibody (green) was used to reveal 
mCD8::GFP in MARCM single-cell clones. 
114 
 
 
 
Figure 5-6.  Preferential cell body and neurite localization of Dscam exon 19 
variants  
(A-D) The TARGET system was used to transiently expressed Dscam exon 19 variants, 
Dscam+19 and Dscam-19, respectively.  Transgenic Dscam-19::GFP was primarily 
targeted to the larval MB axon bundles and weakly to the dendritic calyx (B, D).  Besides 
significantly accumulated in MB axon bundles and the dendritic calyx, transgenic 
Dscam+19::GFP was also abundantly present in cell bodies (A, C).  Antibody 1D4 
(magenta) was used to reveal larval MB lobes.  Anti-GFP antibody (green) was used to 
reveal transiently expressing transgenic Dscam::GFP. 
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Final Conclusions and General Discussion 
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 The work presented in this dissertation is focused on the molecular mechanisms 
that govern the polarized distribution of distinct Dscam isoforms and the elucidation of 
the role of distinct Dscam isoforms in neuronal morphogenesis. These studies indicated 
that distinct Dscam isoforms execute their functions in different neuronal subcellular 
compartments, most likely due to their differential protein distribution. Dscam[TM1], 
which is preferentially targeted to dendrites, mediates dendritic elaboration, while 
Dscam[TM2], which is specifically localized to axons, regulates axonal arborization. In 
addition, Dscam-19 (Dscam lacking exon 19) was more efficiently targeted to neurites 
and acted more potently in altering neurite projection patterns than Dscam+19 (Dscam 
with exon 19). Through the structural functional analysis, dendritic and axonal targeting 
motifs of Dscam were identified in the ectodomain and cytoplasmic juxtamembrane 
segment of TM2, respectively. The dynein/dynactin complex, identified from a 
MARCM-based genetic screen, was shown to be involved in the dendritic restriction of 
Dscam[TM1] through retrograde transport. A dynein/dynactin-independent selective 
transport mechanism and a dynein/dynactin-dependent salvage mechanism were 
demonstrated to work together to ensure the proper localization of Dscam[TM1] to 
dendrites. A sorting mechanism for Dscam[TM1] and Dscam[TM2] into distinct vesicles 
was also suggested.  
 
New insights into the mechanisms underlying the polarized distribution of 
membrane proteins in neurons 
  Compelling evidence has been provided that, as a major minus-end-directed 
motor, the dynein/dynactin complex may not play any role in the initial dendritic 
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targeting of membrane proteins Dscam and Rdl in Drosophila MB neurons. These 
observations raised the possibility that other dendrite-specific plus-end-directed motors 
may be responsible for the selective transport of membrane proteins to dendrites 
(Marszalek et al., 1999; Setou et al., 2000). It is also possible that cargos, not motors, 
determine the destinations of proteins during selective transport (Satpute-Krishnan et al., 
2006). In both situations, identification of the associated motors that specifically 
recognize Dscam[TM1] versus Dscam[TM2] vesicles would help to further dissect out 
the possible roles for these motors in the selective transport mechanism.    
   Axonal retrograde transport, which is mediated by dynein/dynactin, sends 
chemical messages and endocytosis products from the axon terminals to cell bodies. For 
example, earlier studies show that distal uptake and retrograde transport of nerve growth 
factor (NGF) is necessary for survival responses and other trophic effects (Ibáñez, 2007).  
However, it is not clear if retrograde transport is also involved in the polarized 
distribution of membrane proteins. In our study, we uncovered a new function of 
retrograde transport, a salvage mechanism that actively removes mislocalized dendritic 
Dscam from axons. Although this salvage mechanism may not be required for all 
dendritic membrane proteins, such as Rdl, it suggests that a secondary system for proper 
sorting and targeting of membrane proteins may exist in polarized neurons.     
 It would be worth examining whether dynein/dynactin is involved in the polarized 
distribution of other membrane proteins in other model neurons. Recently, a study in 
Drosophila dendritic arborization (da) neurons showed that dynein is required for 
dendritic localization of Golgi outposts and the ion channel Pickpocket. They also 
suggested that dynein function is required for uniform microtubule orientation in axons 
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(Zheng et al., 2008). These findings are different from what we observe in the Drosophila 
MB neurons. Dynein/dynactin dysfunction does not affect the dendritic distribution of 
Rdl and also does not perturb the microtubule orientation in axons. There are some 
intrinsic differences between da neurons and MB neurons. For example, da neurons are 
multipolar while MB neurons are unipolar (Sanchez-Soriano et al., 2005).  Taken 
together, these data indicate that dynein/dynactin function could differ among model 
neurons.    
 The vesicular transport of Dscam[TM1] and Dscam[TM2] was observed in 
Drosophila embryonic cultured neurons (data not shown). The speed of vesicle 
movement was about 1.2 µm/s, which falls into the category of microtubule-based fast 
transport conducted by motors (0.5-2.0 µm/s, Burack et al., 2000). Compared to the slow 
mislocalization process (0.006 µm/s) of Dscam[TM1] caused by dynein/dynactin 
dysfunction, we believe that the mislocalization process is not mediated by motor 
transport. Instead, it could occur through accidental leakage of vesicles into axons which 
cannot be brought back to cell bodies by dynein/dynactin. It could also occur through 
lateral diffusion which cannot be removed from the axonal membrane through the 
endocytotic pathway, although it remains unclear how dynein/dynactin dysfunction 
would affect endocytosis. Further examination of whether mislocalized Dscam[TM1] 
localizes to the plasma membrane or in the cytoplasm would help to clarify the 
mechanisms involved.    
 
Multiple mechanisms are involved in the polarized distribution of membrane 
proteins 
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 Our data support the idea that multiple mechanisms act together to achieve the 
polarized distribution of membrane proteins in neurons. First, from our screen mutants, 
we found that some mutations (group 3) result in cell body retention of Dscam[TM1], 
while another mutation (DC-B9) causes aberrant accumulation of Dscam[TM1] in the 
peduncles of MB neurons, and the other mutation (AC-E10) results in Dscam[TM1] 
evenly distributed throughout the axons without granular accumulation. These intriguing 
phenotypes, which are different from those of dynein/dynactin mutants, suggest presence 
of localization mechanisms other than those involving dynein/dynactin. In addition, a 
mutation in the ion transport peptide (ITP) also leads to the mislocalization of 
Dscam[TM1] in axons. Although there are no reported data on the molecular function of 
Drosophila ITP, the ITP in locusts, which displays sequence similarity to Drosophila 
ITP, is a neuropeptide which has been shown to stimulate the transport of ions across the 
ileal epithelium (Vanden Broeck, 2001). It would be interesting to examine how 
neuropeptide signaling pathways are involved in the polarized distribution of 
Dscam[TM1]. 
 Second, more recent work has found that peptide motifs can target membrane 
proteins to specific subcellular compartments in neurons (Arnold, 2007). However, 
peptide motifs are not conserved across different membrane proteins. In Dscam, we 
found that an axonal targeting motif that consists of both basic (Arg) and acidic (Asp) 
residues. This type of bipartite motif has not been reported before. Interestingly, most 
peptide motifs are located in the endodomains of membrane proteins. However, the 
dendritic targeting motif of Dscam is localized in the ectodomain and is not directly 
recognized by motor proteins, because it is embedded inside the cargo vesicle during 
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transport. These novel findings indicate that the Dscam may utilize different polarized 
targeting mechanisms from the other membrane proteins.  
 Third, it has been shown that the axonal distribution of vesicle-associated 
membrane protein (VAMP)-2 is achieved by uniform delivery to the surface of both 
axons and dendrites and preferential endocytosis from the dendritic membrane. In 
contrast, the targeting of neuron-glia cell adhesion molecule (NgCAM) depends on 
selective transport of cargo proteins to the axonal membrane (Sampo et al., 2003). In the 
case of Dscam, blocking endocytosis with a temperature-sensitive shibire mutant showed 
no obvious effect on its dendritic distribution. However, it remains to be examined 
whether axonal targeting of Dscam depends on the endocytic pathway. Finally, we found 
that the salvage pathway mediated by the dynein/dynactin complex is essential for 
dendritic restriction of Dscam[TM1] but is dispensable for dendritic distribution of Rdl. 
In summary, we believe that different membrane proteins are distributed in a polarized 
fashion in neurons by different combinations of known and unknown mechanisms.  
  
Future studies on the polarized distribution and molecular functions of Dscam  
 Our findings demonstrate that Dscam[TM1] primarily mediates dendritic 
elaboration, and Dscam[TM2] mainly regulates axonal arborization. These distinct 
functional roles in dendrites and axons correlate to the polarized distribution patterns of 
Dscam[TM1] and Dscam[TM2]. The next question to ask is why neurons need some 
Dscam molecules localized to dendrites while others are distributed to axons. Previous 
studies show that Dscam undergoes isoform-specific homophilic binding through its 
ectodomain, and this interaction cell-autonomously leads to the formation of complex 
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morphology of dendrites and axons (Soba et al., 2007; Wang et al., 2002; Wojtowicz et 
al., 2004). Single-cell RT-PCR documented that an individual neuron expresses 14-50 
distinct Dscam mRNAs from the spectrum of thousands of splice variants, and Dscam 
alternative splicing is differentially regulated in different cells (Neves et al., 2004). It 
would be interesting to examine whether, within a single neuron, dendritic Dscam[TM1] 
always couples with certain kinds of ectodomain variants and  axonal Dscam[TM2] binds 
to other types of ectodomains. It is possible that the morphological difference between 
dendrites and axons is related to the usages of different Dscam ectodomain repertoires. 
To verify this hypothesis, genetic manipulation of genomic exon 17.1 and exon 17.2 with 
gene targeting could possibly reverse the choices of ectodomain variants. Reversal of the 
choices of ectodomains between Dscam[TM1] and Dscam[TM2] may result in the 
functional and morphological changes between dendrites and axons.            
 Identification of Dscam[TM1]-specific and Dscam[TM2]-specific associated 
proteins would definitely help to elucidate the polarized distribution mechanisms and 
differential functions of Dscam[TM1] and Dscam[TM2]. To achieve this goal, several 
approaches can be conducted. First, co-immunoprecipitation of GFP-tagged 
Dscam[TM1] and Dscam[TM2] with anti-GFP or anti-Dscam antibodies can enrich 
neuronal lysates for specific associated proteins. The isolated proteins can be 
distinguished from each other and compared using SDS-PAGE. Second, the yeast two-
hybrid system can be employed by using Dscam axonal and dendritic targeting motifs as 
bait to identify associated molecules. Third, genetic screens could also identify additional 
molecules involved in the polarized distribution of Dscam. Further characterization of 
mutants from these screens could reveal potential Dscam-interacting proteins.       
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 In summary, the studies detailed in this dissertation have addressed fundamental 
questions regarding the polarized distribution mechanisms of membrane proteins in 
neurons. The polarized distribution of Dscam[TM1] and Dscam[TM2] serves as a good 
model system to dissect out how neurons properly sort and target different membrane 
proteins to distinct subcellular compartments. The identification of a novel salvage 
mechanism mediated by dynein/dynactin, several prominent mutants involved in 
polarized distribution mechanisms, axonal and dendritic targeting motifs by which 
Dscam is differentially targeted, and potential functions of Dscam associated with its 
polarized distribution have significantly advanced our mechanistic understanding of how 
various Dscam isoforms are differentially expressed and distributed in neurons to 
regulate neuronal morphogenesis. Further elucidation of these basic mechanisms may lay 
the groundwork for future characterization of membrane protein trafficking in polarized 
neurons and help us to understand complex processes that occur in the brain during 
development and daily activities.      
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Appendices 
 
  microRNAs was designed according to the paper Chen et al., 2007. Target 
recognition sequences are underlined.  
Exon 17.1 Target 1:  
(1) D-M7d887-1: 
GGCAGCTTACTTAAACTTAATCACAGCCTTTAATGTCGAGGACACGAT
CCGCATTATCTAAGTTAATATACCATATC 
(2) D-Myd887-2: 
AATAATGATGTTAGGCACTTTAGGTACCGAGGACACGATCCGCATTAT
CTAGATATGGTATATTAACTTAGATA 
Exon 17.1 Target 2:  
(1) D-M7d888-1: 
GGCAGCTTACTTAAACTTAATCACAGCCTTTAATGTCGATAATTGTTAT
TTGTATACTTAAGTTAATATACCATATC 
(2) D-Myd888-2: 
AATAATGATGTTAGGCACTTTAGGTACCGATAATTGTTATTTGTATACT
TAGATATGGTATATTAACTTAAGTA 
 
Exon 17.2 Target 1:  
(3) D-M7d889-1: 
GGCAGCTTACTTAAACTTAATCACAGCCTTTAATGTCAACTTCATGGTG
CCCCTAATTTAAGTTAATATACCATATC 
(4) D-Myd889-2: 
AATAATGATGTTAGGCACTTTAGGTACCAACTTCATGGTGCCCCTAAT
TTAGATATGGTATATTAACTTAAATT 
Exon 17.2 Target 2:  
(3) D-M7d888-1: 
GGCAGCTTACTTAAACTTAATCACAGCCTTTAATGTGACATGCGCGGC
GGCCAAAAGGTAAGTTAATATACCATATC 
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(4) D-Myd888-2: 
AATAATGATGTTAGGCACTTTAGGTACGACATGCGCGGCGGCCAAAA
GGTAGATATGGTATATTAACTTACCTT 
 
 
Exon 18 Target 1:  
(1) D-18 1-1: 
GGCAGCTTACTTAAACTTAATCACAGCCTTTAATGTGCGGGATGAGCT
CGGATACATCTAAGTTAATATACCATATC 
(2) D-18 1-2: 
AATAATGATGTTAGGCACTTTAGGTACGCGGGATGAGCTCGGATACAT
CTAGATATGGTATATTAACTTAGATG 
Exon 18 Target 2:  
(3) D-18 2-1: 
GGCAGCTTACTTAAACTTAATCACAGCCTTTAATGTAATACCTGTGAC
CGGATTAAGCTAAGTTAATATACCATATC 
(4) D-18 2-2: 
AATAATGATGTTAGGCACTTTTAGGTACAATACCTGTGACCGGATTAA
GCTAGATATGGTATATTAACTTAGCTT 
 
Exon 19 Target 1:  
(1) D-19 1-1: 
GGCAGCTTACTTAAACTTAATCACAGCCTTTAATGTCCTGGGACCCTC
GACGCAATCCTAAGTTAATATACCATATC 
(2) D-19 1-2: 
AATAATGATGTTAGGCACTTTAGGTACCCTGGGACCCTCGACGCAATC
CTAGATATGGTATATTAACTTAGGAT 
Exon 19 Target 2:  
(3) D-19 2-1: 
GGCAGCTTACTTAAACTTAATCACAGCCTTTAATGTACGGCCACGCCC
ACGGCAATGCTAAGTTAATATACCATATC 
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(4) D-19 2-2: 
AATAATGATGTTAGGCACTTTTAGGTACACGGCCACGCCCACGGCAAT
GCTAGATATGGTATATTAACTTAGCAT 
 
Exon 18-20 Target:  
(1) D-18-20 -1: 
GGCAGCTTACTTAAACTTAATCACAGCCTTTAATGTATTAAGCGAGGC
ATGGAAGATGTAAGTTAATATACCATATC 
(2) D-18-20 -2: 
AATAATGATGTTAGGCACTTTTAGGTACATTAAGCGAGGCATGGAAGA
TGTAGATATGGTATATTAACTTACTAC 
 
Exon 23 Target:  
(1) D-23-1: 
GGCAGCTTACTTAAACTTAATCACAGCCTTTAATGTGATCTCCACAAC
CGAAAGATCATAAGTTAATATACCATATC 
(2) D-23-2: 
AATAATGATGTTAGGCACTTTAGGTACGATCTCCACAACCGAAAGATC
ATAGATATGGTATATTAACTTAGATATGAT 
 
Exon 22-24 Target:  
(1) D-22-24 -1: 
GGCAGCTTACTTAAACTTAATCACAGCCTTTAATGTGGAAACTACGGA
GAAACGAAACTAAGTTAATATACCATATC 
(2) D-22-24 -2: 
AATAATGATGTTAGGCACTTTTAGGTACGGAAACTACGGAGAAACGA
AACTAGATATGGTATATTAACTTAGTTT 
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